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Chapter 1 
 
 
General introduction 
 
 
 
 
1.1  Tissue engineering  
Severe disease or injury can cause malfunction or damage of tissue and organs in human body. The 
diseased or damaged body structures are treated with drugs, artificial prosthesis or transplantation of tissue or 
organs from one individual to another. However, drugs neither fully heal the tissue with major damage nor 
achieve its long-term recovery. Artificial prosthesis can only restore partial function of a tissue and cannot 
sufficiently integrate with host tissue and need to be replaced when they are worn out after 15 - 20 years. 
Transplantation techniques have many constraints. The major constraint is the lack of living tissue and 
organs for transplantation. According to the Organ Procurement and Transplantation Network (United States), 
the waiting list candidates for transplantation as of November 12th, 2015 are 122,719; the transplants 
performed during January - August 2015 are 20,705. The gap between need and supply continues to widen. 
In addition, the immune system produces chronic rejection of the transplanted graft over time. The reduction 
of activation of immune system (immunosuppression) to reduce the rejection can cause new tumor 
formation. 
In this context, tissue engineering emerged as a new solution to these problems.[1, 2] Human cells are 
cultured and manipulated to form living tissue that can be transplanted to repair and restore the function of 
damaged tissue or organ. A small fraction of a tissue is harvested to isolate the cells, without the need of 
taking the whole tissue or organ as in transplantation. Living tissue can be engineered from the cells of the 
patient, which reduce the risk of rejection and need of immunosuppression.   
1.1.1  The principle of tissue engineering  
The principle of tissue engineering is depicted in Fig. 1.1. In essence, cells are isolated from a fraction 
of human tissue and cultured in vitro to expand cell number. Then the cells are harvested and cultured with 
bioactive molecules in a three-dimensional (3D) scaffold material in vitro. During the in vitro culture, cells 
grow and produce extracellular matrix (ECM) within the 3D scaffold which turn into an engineered tissue. 
The engineered tissue is transplanted into human body to treat the diseased body structure. 
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Fig. 1.1. The principle of tissue engineering. 
1.1.2  Cells  
The cells isolated from human tissue can be fully differentiated cells of target tissue, progenitor cells or 
stem cells. Fully differentiated cells such as dermal fibroblasts and articular cartilage cells (chondrocytes) 
can be used to engineer skin tissue or cartilage tissue, respectively. One FDA approved skin product involves 
the use of neonatal human dermal fibroblasts from foreskins. The fibroblasts are expanded in vitro and 
cultured in a porous poly(lactide-co-glycolide) scaffold that can be gradually degraded by hydrolysis. After 
the culture a dermal layer of skin can be engineered for transplantation. Progenitor cells are the cells with the 
capability to differentiate in to limited cell lineages. One example of progenitor cells is skeletal muscle 
progenitor cells (myoblasts), which can be differentiated into mature muscle fiber. Myoblasts isolated from 
muscle tissue can be cultured in 3D scaffolds to engineer muscle tissue to repair the muscle tissue loss. Stem 
cells, either from adults or from embryos, have the ability to self-renew and differentiate into many cell 
lineages such as bone cells (osteoblasts), chondrocytes, tendon cells, etc. Because the source of some types 
of differentiated cells or progenitor cells for tissue repair are very limited or hardly accessible, stem cells 
have been studied for tissue engineering. Stem cells can be expanded in vitro while keeping their 
undifferentiated state. To apply stem cells in tissue engineering, studies were focused on better ways to 
expand stem cells and differentiate them to the desired cell type. 
In some culture systems one type of cell was used to engineer new tissue but other culture systems 
multiple types of cell were used. Culturing multiple types of cells in a 3D scaffolds mimics the complex 
organization of normal tissue and achieve the multiple functions of the tissue. For example, fibroblasts were 
cultured in collagen matrixes on which a layer of karatinocytes were cultured, which form a living dermal 
equivalent (ICX-SKN) for the treatment of burns and acute wounds.[3, 4] Skeletal muscle cells were cultured 
with vascular endothelial cells in polymer scaffolds to generate the vascularized muscle tissue to improve the 
viability of engineered tissue in vivo.[5] In some studies, skeletal muscle cells, vascular endothelial cells and 
fibroblasts were cultured in polymer scaffolds to engineer vascularized muscle tissue, where the fibroblasts 
can enhance the vascularization and stabilize the newly formed vascular network.[6] 
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1.1.3  Bioactive molecules  
Bioactive molecules such as growth factors, cytokines and hormones were used in tissue engineering to 
control cell function and tissue formation. Among them growth factors are the mostly used bioactive 
molecules to affect cell proliferation, differentiation and morphogenesis. Growth factors are usually proteins 
that can act on the receptors of cell surface, which initiate the changes of cell behaviors, according to the 
type of growth factors. For example, bone morphogenetic proteins can affect the postnatal bone formation 
and are used in therapeutic treatment such as bone defects and bone fractures and osteoporosis. Transforming 
growth factor beta-1 is used to promote the chondrogenic differentiation of stem cells to chondrocytes and 
formation of cartilage tissue.[7] Fibroblast growth factor (FGF) and vascular endothelial growth factor 
(VEGF) are found to affect the tubule formation of vascular endothelial cells and stabilize the newly formed 
vascular tubules.[8] Chondrogenic induction medium containing transforming growth factor beta (TGFβ) can 
cause an upregulation of smooth muscle actin-alpha (α-SMA) in bone marrow stromal cells (BMSC), which 
lead to shrinkage of scaffolds. Addition of basic fibroblast growth factor (bFGF) in the chondrogenic 
induction medium can suppression the expression of α-SMA and reduce the shrinkage of engineered tissue 
from BMSC and improve cartilage tissue formation.[9] 
Growth factors can be supplemented in the cell culture medium during in vitro culture, or incorporated 
into a scaffold system to affect cell behavior. For example, insulin supplemented in the differentiation 
medium of skeletal myoblasts can facilitate the fusion of myoblasts into mature myotubes. A porous 
scaffolds with tethered VEGF could induce the infiltration of vascular network after its transplantation in 
animal body.[10] Growth factors can be encapsulated in polymer micro-/nano-particles which were 
incorporated into porous scaffolds.[11, 12] The encapsulation of growth factors in polymer particles prepared 
from degradable polymer make it possible to control the release of growth factors. The degradation of the 
polymer and therefore the release profile of the encapsulated growth factor can be tailored by the chemical 
structure of polymer and the size of microparticles.  ors in a spatiotemporally controlled manner, which is 
critical to manipulate the behavior of cell cultured in the scaffolds or the cell infiltration from surrounding 
tissue into the scaffolds. In addition, multiple kinds of growth factors can be encapsulated in different kinds 
of polymer microparticles in scaffolds to control the release of multiple kinds of growth factor at the same 
time.  
1.1.4  Scaffolds  
In tissue engineering, a scaffold is the 3D material that support cell adhesion, proliferation, synthesis of 
ECM and control the shape of engineered tissue. Scaffolds can be porous or hydrogel, both of which can 
accommodate cells cultured in the 3D material.  
Scaffolds for tissue engineering need to meet the requirements as show below:  
I. Biocompatibility 
Scaffolds should be compatible with cells cultured in them and the surrounding living tissues where 
they are implanted. Scaffolds should allow the attachment and proliferation of cells and maintain the 
specific function of cells. Scaffolds and their degradation products should not be toxic to the cells and 
the surrounding tissue after implantation. Implanted scaffolds should not adversely affect the function of 
organs or the whole body. In addition, the inflammatory response to an implant, the formation of fibrous 
capsule that isolate the implant with the surrounding tissue should be avoided to allow the integration of 
the implant with surrounding tissue. 
II. Degradability 
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Scaffolds should be degradable through hydrolysis or enzymatic digestion. The breakdown of scaffolds 
need to coordinate with the growth of new tissue while maintain the structural integrity of the 
cell/scaffold construct during cell culture or after implantation. Finally, the implanted scaffold should be 
replaced by the engineered tissue. 
III. Mechanical property 
The mechanical property of scaffolds should be strong enough to allow surgical handling and withstand 
the cellular contraction and the mechanical load at the site of implantation. Many types of cells such as 
dermal fibroblasts, chondrocytes and muscle cells contract the scaffolds in which they are cultured, 
which makes it hard to control the final size or shape of engineered tissue. In addition, some tissues 
such as cartilage, ligament and bone are frequently subjected to mechanical load. Therefore, 
regeneration of these tissues necessitates a mechanically strong scaffold. It is noteworthy, however, that 
in some cases a too stiff scaffold might adversely affect cell behavior such as the differentiation of stem 
cells, which is influenced by the substrate stiffness. 
IV. Pore structure 
Scaffolds with proper pore structure such as open pores and controlled pore size are necessary to 
engineer a 3D tissue. Scaffolds with open, interconnected pore structure can enable cell infiltration into 
the whole space of scaffold and homogeneous distribution of cells and formation of a homogenous 
tissue. In contrast, a scaffold with closed pores will hinder cell infiltration into the bulk material, which 
leads to the cell growth and tissue formation on the peripheral region of the scaffold. On the other hand, 
engineering of tissues with well-ordered structure such as muscle and nerve necessitate scaffolds of 
well-ordered pore structure that guide the cell assembly and tissue orientation within the cell/scaffold 
construct. 
 
Scaffolds are commonly used in tissue engineering because in many cases cell therapy alone cannot 
successfully engineer the target tissue. One example of cell therapy without scaffold material is autologous 
chondrocyte implantation (ACI). Chondrocytes were isolated from the non weight-bearing cartilage and 
cultured in vitro to increase their number. The expanded chondrocytes were then injected into the cartilage 
wound sutured with a periosteal flap taken from a lower leg bone. The injected chondrocytes will grow and 
form cartilage tissue in the wound. The ACI method has problems such as cell leak from the sutured wound 
due to the holes or tears of the fragile periosteal flap and the hypertropy of new tissue associated with the 
flap. As a another example, skin cells such as karatinocytes can be cultured to get epidermis for 
transplantation but it cannot repair the full-thickness skin wound. To solve the problems of ACI method, 3D 
collagen matrices are used to culture chondrocytes or load chondrocytes just prior to transplantation to repair 
cartilage tissue. Collagen matrices with or without dermal fibroblasts can be implanted into skin wound to 
regenerate the 3D dermal skin layer. 
1.2  Porous scaffolds for tissue engineering  
There are four major scaffolding approaches for tissue engineering: pre-made porous scaffolds, 
decellularized extracellular matrix, cell sheet with synthesized extracellular matrix and cell-encapsulated 
hydrogel (Fig. 1.2). [13] Each kind of approach has its advantages and disadvantages. Pre-made scaffolds 
can have tailored pore structure and mechanical property but usually cannot enable homogenous distribution 
of cells after cell seeding. Decellularized extracellular matrix can mimic the composition of normal tissue but 
they have uncontrolled pore structure, inhomogeneous distribution of cells and possibly carry pathogens or 
cause immunogenicity after implantation. Cell sheet with synthesized extracellular matrix have good 
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compatibility with the surrounding tissue after transplantation but they need numerous stacking to obtain 
thick tissue. Cell-encapsulated hydrogel can be injected into wounded tissue for regeneration but their 
mechanical property is too weak. Among the four approaches, pre-made porous scaffolds can be used to 
engineer soft and hard tissues. The present study focused on improving the micropore structure of pre-made 
porous scaffolds to enable homogenous cell distribution and tissue formation, controlled cell assembly and 
behavior. Therefore, pre-made porous scaffolds with detailed information are introduced below. These 
scaffolds are developed from biodegradable polymers, either synthetic or naturally occurring.  
 
 
Fig. 1.2. Major scaffolding approaches for tissue engineering.  
 
1.2.1  Synthetic polymer-based scaffolds  
The most investigated biodegradable synthetic polymer for tissue engineering are aliphatic polyesters 
and polyurethanes. Poly(glycolic acid) (PGA), poly(lactic acid) and their copolymers poly(lactic 
acid-co-glycolic acid), which are aliphatic polyesters, are the most common biodegradable polymers used in 
medicine (Fig. 1.3). PGA is more hydrophilic than PLA and PGA is highly crystalline. PGA was used as 
clinical sutures and they had a crystallinity of about 46-52%.[14, 15] Because of their water uptake and 
hydrophilic property, the PGA based sutures usually had a degradation time of 2-4 weeks after 
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implantation.[14] PLA has a methyl group on the polymer backbone, which makes it more hydrophobic. The 
small water uptake of PLA (less than 2% for PLA films) make it harder to degrade via hydrolysis. While 
PGA is highly crystalline, PLGA has a reduced crystallinity due to presence of PGA in the backbone. As a 
rule, more PGA in PLGA results faster degradation rate. However, PLGA with 50:50 ratio of PGA and PLA 
has the fastest degradation.[16] In spite of their biodegradability, PGA or PLGA based resorbable pins 
sometimes cause a late noninflammatory response.[17] After implantation of PGA for 12 weeks or PLA for 
as long as 3 years, this unwanted response happened, which was suggested to be the result of acidic 
degradation products (glycolic acid for PGA and lactic acid for PLA). 
PGA fibers have been used to develop into cylinder porous PGA scaffolds to culture chondrocytes to 
engineer cartilage tissue.[18-21] Porous PLA, PGA and PLGA scaffolds has been used to engineer tissues as 
well as their combined product with bioglass such as hydroxyapatite.[22] The combination with bioglass 
significantly improved the mechanical property of porous polymer scaffolds and the regeneration of bone 
tissue. PGA mesh scaffolds were cultured with endothelial cells and smooth muscle cells isolated from blood 
vessels to engineer small-diameter vessel grafts, during which the polymer degraded and ECM was 
synthesized[23-25]. After removal of cells in the engineered vessels, the grafts were implanted in dog model 
which showed no immunogenic response and maintained resisted dilation and hyperplasia. 
 
Fig. 1.3. The chemical structure of PLA, PGA and PLGA. 
1.2.2  Natural polymer-based scaffolds   
Natural polymers can be used to prepare porous scaffolds for tissue regeneration. Natural polymers are 
produced by living organisms and can be categorized as peptide and proteins, polysaccharides, 
polyhydroxyalkanoates, and polynucleotides. The first two categories are usually used to prepare porous 
scaffolds, which are usually modified or crosslinked to control their degradation to support cell culture and 
tissue formation. In the present study, natural proteins (collagen and gelatin) and polysaccharide (hyaluronic 
acid) are used to develop porous scaffolds to culture skin cells (dermal fibroblasts), cartilage cells 
(chondrocytes) and muscle cells (myoblasts). Therefore, their chemical structure, presence and function in 
living tissues and applications for tissue regeneration are summarized. 
 
I. Collagen 
Collagen is the major structural protein of extracellular matrix of normal tissue and account for about 
30% of all the proteins of human body. There are about 14 types of collagens in human body and type I 
collagen is the major component. However, the presence of each type is dependent on the type of tissue. For 
example, type I collagen are the major protein in tendon, skin and bone; type II collagen are the major 
protein in articular cartilage. The basic unit of collagen is a polypeptide helix with the repeating sequence of 
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glycine-X-Y, where X and Y are frequently proline or hydroxyproline. Triple helix of such peptides 
assembled through hydrogen bonding into collagen fibrils, which further closely packed into collagen fibers 
to support the living cells and tissues. [32] For example, collagen assembled into strong aligned bundles in 
tendon while it randomly distributed in dermal skin.  
Collagen has been developed into porous scaffolds to regenerate varied types of tissues. As a natural 
protein that support cells in tissue, collagen is highly compatible with cells and tissues. A porous collagen 
scaffolds can be implanted into skin wounded to induce the infiltration of cells from surrounding tissue into 
the porous material to synthesis new skin tissue.[26, 27] The pore structure and degradation time of collagen 
scaffolds can be controlled by using different freezing condition during freeze-drying and crosslinking 
density. Collagen scaffolds with proper pore size and degradation time had the optimal skin regeneration 
result.[27] To reduce the immunologic responses to the collagen material after implantation, type I collagen 
is treated with pepsin and purified to obtain atelocollagen.[28-31] 
 
 
II. Gelatin 
Gelatin is derived from partial acidic or alkaline hydrolysis of collagen. Gelatin is compatible with cells 
and tissues due to the similar chemical composition of gelatin and collagen. In addition, gelatin has low 
antigenicity compared to collagen.[33-35] Gelatin solution gels at a low temperature (0 - 25 ºC) and the 
gelation is dependent on the concentration of gelatin and temperature. The greater the concentration of 
gelatin, the more quickly the solution gels. Gelatin solution at a lower temperature gels more quickly. 
Freeze-drying gelatin solutions results in porous gelatin scaffolds. Porous gelatin scaffolds were used to 
engineer various kinds of tissues such as skin, cartilage and bone. For example, gelatin and 
glycosaminoglycans (a kind of polysaccharides) have been developed into porous scaffolds to culture 
articular chondrocytes to regenerate articular cartilage tissue. 
 
III. Hyaluronic acid 
Hyaluronic acid (HA), also named hyaluronan, is a linear polysaccharide with repeating disaccharides 
(D-glucuronic acid and D-N-acetylglucosamine) (Fig. 1.4). The number of repeating disaccharides can reach 
as great as about 10,000 and the molecular weight of HA can be as high as 4, 000 kDa. HA is synthesized by 
various types of cells such as fibroblasts and chondrocytes and HA is abundant in many types of animal 
tissues.  
HA is the unsulfated glycosaminoglycan in ECM and can affect tissue functions and cell behaviors. HA 
presents in biological fluids such as the synovial fluids and the viscous fluids containing HA lubricate the 
surrounding articular cartilage. Cell receptors such as CD44 (cell surface glycoprotein), ICAM-1 
(intracellular adhesion molecule-1) and RHAMM (receptor for HA-mediated motility) can interact with HA 
which affect cell behavior such as migration and differentiation. Found on the cell surface and in cytosol, 
RHAMM can regulate cell behavior in the presence of growth factors and affect the migration of fibroblasts 
and smooth cells. During the development of skeleton and limb buds and morphogensis of bone, there is a 
period when HA is produced followed by the destruction of HA. In addition, it has been found that the 
production of HA was associated with mescenchymal cell migration and the destruction of HA associated 
with cell differentiation. For example, chondrogenesis in the embryo limb buds and axial skeleton has a 
period of accumulation of mescenchymal cells and production of HA, followed by removal of HA by 
enzyme (hyaluronidase) and differentiation of the cells to form cartilage tissue. 
Due to its chemical and biological properties, HA has been used to form porous scaffolds for tissue 
engineering. The hydrophilic and bioactive HA has good compatibility with cells and living tissues. Because 
HA is easily dissolved in water and has a high rate of turnover in animal body, HA need to be modified and 
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crosslinked to act as a temporal scaffold material for cell growth and tissue formation. The functional groups 
on the backbone of HA such as carboxylic group and hydroxyl group provide abundant modification sites. 
Crosslinking methods such as water-soluble carbodiimide crosslinking and modifications such as 
methacrylation of HA molecules, are used to stabilize HA and extend its degradation. HA based scaffolds has 
application in regeneration of skin and cartilage and bone. However, the effect of HA on the behavior of 
chondrocytes in 3D culture remain controversial. While some studies showed increasing amount of HA in 3D 
scaffolds resulted in higher chondrocyte proliferation or more cartilage ECM synthesis, other studies showed 
that a low amount of HA in 3D scaffolds favor chondrogenesis and higher amount of HA caused an 
inhibition of chondrogenesis.[36-38] These 3D scaffolds usually had uncontrolled pore structure and 
non-uniform distribution of HA, which could interfere the effects of HA on cell behavior. 
 
 
Fig. 1.4. Chemical structure of one unit in the chain of hyaluronic acid (left) or chondroitin sulfate (right). 
Chondroitin-4-sulfate: R1, R3 = H; R2 = SO3H. Chondroitin-6-sulfate: R1 = SO3H; R2, R3 = H. 
 
IV. Chondroitin sulfate 
Chondroitin sufate (CS) is a linear polysaccharide with a repeating disaccharide (N-acetylgalactosamine 
and glucuronic acid) (Fig. 1.4).  CS is a kind of sulfated glycosaminoglycans present in many kinds of 
tissues such as skin and cartilage. The location of sulfate groups on the repeating disaccharide varies and 
each variant has its corresponding name such as chondroitin-4-sulfate and chondroitin-6-sulfate. CS variants 
affect cell functions differently. For example, supplement of chondroitin-6-sulfate increased the synthesis of 
mRNA for type II collagen in the 3D culture, while supplement of chondroitin-4-sulfate did not.[37] CS 
bonds to proteins to form proteoglycans such as aggrecan which is the major proteoglycan in the ECM of 
cartilage tissue. Aggrecan act as the structural protein in cartilage to absorb the mechanical impact and resist 
the compression during joint movement or load-bearing activities. Because CS were found to enhance the 
synthesis of cartilage ECM, supplement of CS were used to repair damaged cartilage or alleviate the 
symptoms of osteoarthritis. 
As one kind of sulfated glycosaminoglycans (sGAG), CS is usually combined with other natural 
polymer to prepare porous scaffolds for tissue engineering. For example, the mixed suspension of CS and 
collagen were freeze-dried to prepare porous collagen/glycosaminoglycan (CG) scaffolds. Because both 
collagen and glycosaminoglycans are the inherent component of ECM, CG scaffolds are bio-mimetic and 
compatible with various types of cells and used for engineer various types of tissues such as skin, cartilage, 
tendon and bone. The commercialized product, Integra Dermal Regeneration Template is a porous bovine 
collagen crosslinked with chondroitin-6-sulfate with an upper layer of silicone, which is used to regenerate 
full-thickness skin wounds. Another product, Menaflex (Regenbiologics), is a bovine collagen with HA and 
CS for the regeneration of cartilage tissue. 
 
V. Chitosan 
Chitosan is a linear polysaccharide composed of repeating units of N-acetyl D-glucosamine and 
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D-glucosamine. Chitosan is derived from partial deacetylation of chitin, which is abundant in the rustacean 
shells or insect cuticles (Fig. 1.5). The degree of deacetylation (DD) refers to the ratio of D-glucosamine 
number to the sum of N-acetyl D-glucosamine and D-glucosamine numbers. Chitosan usually are the form of 
chitin that has 60% glucosamine (DD = 60). While chitin has limited application as a biomaterial due to its 
low solubility, chitosan has many good properties to make it for medical applications. Chitosan can be 
dissolved in acidic solution and its amine groups become protonated, which give the chitosan positive 
charges. Chitosan has a mucoadhesive property because the negative glycoprotein in mucin can bind to the 
positively charged chitosan, and the mucoadhesive ability can be improved by using chitosan with greater 
DD.[39] Similarly, negatively charged blood cells can interact with chitosan, a haemostatic activity to stop 
bleeding.[40-42] 
Chitosan sponges are mainly prepared from freeze-drying method and they are mainly used as wound 
dressing to absorb the wound exudates and facilitate wound healing.[43] As a natural polymer with good cell 
interaction, chitosan are prepared into scaffolds to be used in regeneration of tissues such as bone.[44-47] 
Chitosan, tricalcium phosphate and collagen can be combined to prepare composite scaffolds for bone tissue 
engineering. Culture of rat osteoblasts in 3D chitosan/tricalcium phosphate scaffolds showed that the 
material could support the cell proliferation, high activity of alkaline phosphatase and synthesis of 
mineralized ECM.[48] Culture of rat bone marrow stromal cells on 3D chitosan/collagen scaffolds showed 
that the material promoted osteogenic differentiation of the cells compared with chitosan scaffolds or 
collagen scaffolds.[49] 
 
 
 
Fig. 1.5. Deacetylation of chitin to obtain chitosan. 
 
VI. Silk fibroin 
Silk fibroin is a natural polymer derived from silk produced by the silkworm Bombyx mori and the 
spider Nephila clavipes.[50] The mostly studied silk fibroin as biomaterial is from cocoon silk of the 
silkworm. Those silk has the core protein of silk fibroin, and glue-like coating of sericin protein which has 
been found cause adverse immune responses of silk-based material. Silk fibroin contains hydrophobic blocks 
with repeating amino acids that has short side chains and hydrophilic blocks with amino acids that has long 
side chains. Silk fibroin has strong mechanical property, good compatibility with cells and slow degradation, 
which make it suitable for biomedical applications. The original silk is insoluble in water, ethanol or dilute 
acid but it can be dissolved in the solvent of hexafluoroisopropanol (HFIP) or concentrated lithium bromide 
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solutions to extract silk fibroin. Silk fibroin based materials can be autoclaved or treated with 90% methanol 
to induce the formation of beta-sheet structure to make them insoluble in water.[51] Silk fibroin can be made 
into various forms such as films, coatings, hydrogels, membranes and 3D porous scaffolds.  
Silk fibroin based porous scaffolds has applications in engineering of skeletal tissues such as ligament 
and bone and connective tissues such as skin.[52-57] Porous scaffolds prepared from synthetic polymer were 
coated with silk fibroin to facilitate cell adhesion. For example, polyurethane scaffolds were dipped into 4 
wt.% silk fibroin solution to give a protein coating with the thickness of 200 - 600 nm.  The coating on the 
3D scaffolds significantly enhanced the adhesion, proliferation and synthesis of ECM of fibroblasts. In 
addition, inflammation-related cytokines during wound repair such as IL-1β, TNF-α, and TGF-β1 were 
undetected.[58] 3D porous silk fibroin scaffolds can be prepared with salt leaching method with the use of 
aqueous and HFIP solution of silk fibroin. Scaffolds from both kinds of solutions had the transition of silk 
fibroin protein structure, from random coil to β-sheet, which can strength the scaffolds and slow their 
degradation. Compared with the HFIP-derived scaffolds, the aqueous solution-derived scaffolds had pores 
with rough and hydrophilic surface and good pore interconnectivity.  
The amino acid side chains of silk fibroin provide abundant modification sites to incorporate other 
bioactive molecules such as RGD and growth factors. RGD coupled silk fibroin fibers promoted the 
attachment, spreading, proliferation and differentiation of bone marrow stromal cells.[59, 60] Bone 
morphogenetic protein-2 (BMP-2) was chemically coupled on silk fibroin, which retained the growth factor 
with a higher level compared to the BMP-2 physically absorbed on silk fibroin.[61]    
1.3  Fabrication methods of porous scaffolds  
The fabrication methods of porous scaffolds can be categorized into (1) porogen-based methods, (2) 
solid freeform fabrication techniques and (3) fiber based methods.[13]  
1.3.1  Porogen-based methods 
In the first category, polymer suspension or solution are mixed with porogen materials which can be 
gases such as carbon dioxide, liquids such as water and solids such as sodium chloride particles or paraffin 
microspheres. After removal of the porogen in the mixture by sublimation, evaporation or dissolution of solid 
particles by an appropriate solvent, a porous polymer scaffolds can be obtained. Methods of the first category 
are particle leaching, freeze-drying and gas foaming (Fig. 1.6).  
Particle leaching allows the preparation of scaffolds with controlled porosity and pore size. Polymer 
solution is casted in a mold with porogen particles. The porogen can be inorganic particles such as sodium 
chloride particles or organic particles such as saccharides, gelatin or paraffin microspheres. Evaporation of 
the solvent resulted in the polymer matrix embedded with porogen material. The porogen material can be 
dissolved in a proper solvent such as water for sodium chloride particles or aliphalic solvent for paraffin 
microspheres, leaving behind a polymer matrix with porous structure. The pore size and porosity of scaffolds 
can be controlled by using porogens with certain sizes and the ratio of porogen to the polymer solution. The 
advantages of this method are that no special equipment is required and the pore size and porosity can be 
independently controlled. However, due to the need of removing porogen embedded in polymer matrix, the 
scaffolds are limited to a thickness of about 2 mm. In addition, the agglomeration of porogen can hinder the 
formation of homogeneous pore structure. The organic solvents used during the fabrication, if not removed, 
can be toxic to cells or affect the efficacy of bioactive molecules.[62-64] 
Freeze-drying can be used to prepare porous polymer scaffolds. The method comprises two stages, 
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freezing a solution and removal of the solvent. During the freezing, the polymer solution is cooled down to 
form ice crystals, which force the aggregation of polymer in the interstices. Then the frozen solution is put 
under a low pressure to sublimate the solvent. When the frozen solvent is sublimated, the unfrozen absorbed 
water in the polymer matrix can be removed by slightly increase the temperature of sample. The pore 
structure of the final porous scaffolds depends on the freezing rate, final freezing temperature and pH.[65, 
66] A highly porous scaffolds can be prepared by using this method. However, this method has problems 
such as the random pore structure and heterogeneity of polymer matrix of scaffolds. 
Supercritical fluid method generates pores in polymer by using polymer disk equilibrated with 
high-pressure carbon dioxide (CO2). Polymer disk from PLA, PGA or PLGA can be prepared by using 
heating and compression, or by drying a polymer solution. The polymer disk is then put in a chamber with 
high pressure CO2 (5MPa) and equilibrated for 72 hours at room temperature. Finally the CO2 gas in the 
chamber is released in 15 seconds to reach the atmosphere pressure, during which the gas nucleate and form 
bubbles making the polymer material highly porous. A porosity as high as 93% could be obtained with this 
method. This method can prepare porous polymer scaffolds without the use of organic solvents. However, it 
results the closed pore structure and a skin layer on the porous scaffolds. [67, 68] 
 
Fig. 1.6. a, Porogen leaching method. A polymer solution is casted in a molded porogen. Sublimation of the 
solvent and removal of the porogen results in a porous polymeric structure. b, Freeze-drying method. A 
polymer solution is frozen to from the ice crystals of solvent. The frozen solvent is sublimated by treating the 
sample in a pressure lower than the equilibrium vapor pressure of solvent, leaving behind a porous scaffolds. 
c, Supercritical fluid method. A polymer sample is saturated with high pressure of carbon dioxide (CO2) and 
an abrupt reduction of the air pressure results in CO2 air bubbles to form a porous scaffolds.  
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1.3.2  Solid freeform fabrication 
Solid freeform fabrications enable fabrication of scaffolds that has the complex structure of target tissue 
to be repaired. Fabrication of porous scaffolds by using solid free-form methods usually depend on two types 
of systems. One type is laser-based system such as stereolithography which polymerizes the photopolymer 
solution and selective laser sintering which sinter the powered material. The other type is printing-based 
system such as 3D printing which deliver liquid adhesion to a moving bed of powered material and wax 
printing which deposit the object and support materials in sequence. [70] 
Patient image date are usually used to prepare porous scaffolds of defined shape. Firstly, the target tissue 
to be repaired are scanned with medical imaging such as computed tomography and magnetic resonance 
imaging to obtain the digital information of the tissue's shape and size. The information of target tissue can 
be converted into a digital file that describes the slices with defined thickness (cross section of the target 
tissue). Secondly, with the digital information the porous scaffolds are fabricated in a layer-by-layer manner. 
Some methods (stereolithography, selective laser sintering) use energy such as light or heat to solidify the 
predetermined points of space in the soluble material bed or a powered material bed, which led to formation 
of porous scaffolds with hierarchical pore structure. Other methods (3D printing, wax printing) print 
materials from the bottom layer to the top layer to generate scaffolds of predefined shape and size. 
Solid freeform techniques allow fabrication of complex, customized scaffolds, minimal manual 
handling, accurate and consistent pore structure and mechanical property and various kinds of processing 
conditions (solution, solid or powder). Shortcoming of these methods are the use of organic solvent, 
dependence on the expensive equipment, high temperature and limited material that can be processed and 
pore occlusion at the boundary of scaffolds.[69] 
1.3.3  Fiber based methods 
Fiber based methods such as fiber bonding or electrospinning are used to prepared porous scaffolds. 
Fiber bonding which involves the knitting or bonding of fibers are able to prepare a 3D fiber meshes. Fibers 
are prepared by wet, dry spinning methods. For example, the fibers of a PGA mesh can be bonded by a 
solution of PLGA or PLLA and after evaporation of solvent, a physically stable PGA mesh can be obtained. 
Electrospinning is another method to prepare 3D meshes (Fig. 1.7). The electrospinning device comprises a 
high voltage supplier, a syringe pump that supply polymer solution, and a metal collector. Polymer solution 
are charged by the high voltage and ejected from the capillary tube to the metal collector, during which the 
viscoelastic force of polymer solution stabilizes the fiber. Fibers with diameter as small as 50 nm can be 
collected and mounted to form a polymer mesh. The electrospinning parameters that can affect the formation 
of fiber are the molecular weight of polymer, viscosity and surface tension of polymer solution, voltage, the 
distance between the tip and the collector, ambient temperature and humidity. The disadvantages of this 
method are that numerous parameters need to be optimized and the tiny pore structure of electrospun 
scaffolds which can hinder the cell migration into the inner scaffolds. [71] 
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Fig. 1.7. Schematic representation of the electrospinning set-up for fabrication of porous scaffolds.  
1.4  The effect of scaffold properties on cell behavior  
The physical and biochemical properties of scaffolds for tissue engineering can affect behaviors of cells 
cultured in vitro or in vivo. Porous scaffolds with varied micro-/nanostructure, mechanical property and 
biochemical composition can be fabricated by using varied fabrication techniques and/or different kinds of 
polymers. Cell behaviors such adhesion, spreading, migration, proliferation, phenotype and assembly can be 
influenced by scaffold properties in vitro. In addition to these cell behaviors, porous scaffolds can also 
initiate cell responses in vivo such as foreign body response (FBR). 
Cell adhesion and spreading are the first events since cells get in contact with scaffolds. Many types of 
cells need to adhere to a suitable substrate to maintain their viability. Methods to quantify cell adhesion to 
scaffolds vary. A simple method to quantify the cell adhesion usually involves three steps: 1) cell suspension 
is dispensed on a scaffold, 2) incubate the cells with the scaffold for a certain period of time, and 3) washing 
away the unattached cells and quantify the unattached cells or cells in the scaffolds. Cell migration in 
scaffolds, which is usually affected by the pore structure and composition of scaffolds, are usually based on 
visual observation of cell-seeded cultured for certain period of time. Cell/scaffold construct can be sectioned 
and stained with histological staining to check the cellular distribution in the scaffolds. In general the cells 
cultured in scaffolds are expected to possess a specialized phonotype. For example, hepatocytes in liver 
tissue have functions such as protein secretion and detoxification. Therefore the ability of hepatocytes in 
scaffolds to secret proteins and intracellular enzyme activity are usually analyzed. Production of 
tissue-specific ECM such as collagen and GAGs is required for chondrocytes, osteoblasts and fibroblasts. 
Cell assembly or aggregation is another behavior that can modulated by scaffold properties. One example is 
the assembly of vascular endothelial cells to form tubular vascular structure with the use of type I collagen.  
After implantation of polymer scaffolds in animals, the scaffolds usually initiate the host cell responses 
such as FBR. FBR are the overlapping events that include protein adsorption, inflammatory cell (primarily 
neutrophils and macrophages) recruitment, foreign body giant cell formation and fibroblasts involvement. 
The result is the formation of a layered collagen fiber (fibrous capsule) that isolates the implant from the host 
tissue, which can hinder the integration of engineered tissue with host tissue and vascularization of the graft. 
1.4.1  The effect of pore structure  
The pore structure of scaffolds can affect the cell behaviors such as distribution, migration, assembly 
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and tissue formation. Cells in normal tissue are resided in a ECM with specific micro-/nanostructure. For 
example, tendon cells has the ECM with aligned collagen fibers. Many research studied on the effect of 
scaffold pore structure on cell behavior. The open-pore structure of scaffolds is the premise to enable 
homogeneous cell seeding and homogenous tissue formation. Some research used homogeneous scaffolds 
with isotropic and open pore structure can enable a homogeneous distribution of cells and formation of a 
homogenous tissue.[72-74] PLGA scaffolds with microtubule oriented pores facilitated formation of thick, 
homogeneous cartilage tissue with greater mechanical strength and higher amount of cartilage ECM.[75]  
Scaffolds with anisotropic pore structure shows a great potential to engineer highly ordered tissues such 
as skeletal muscle. Unidirectional freeze-drying is a fabrication technique to generate oriented pores in 
natural polymer based scaffolds. Collagen scaffolds with parallel pores (pore width: 20-50 µm) were seeded 
with C2C12 skeletal myoblasts and aligned myotubes formed along the pores in these scaffolds. These 
cell/scaffolds constructs were implanted in the tibial muscle of immunodeficient mice and the implants 
integrated with the surround muscle tissue, forming functional muscle tissue from donor myoblasts and host 
muscle cells.[76] Another study used the similar method to develop chitosan scaffolds with unidirectional 
microtubule pores, which enabled formation of myotubes of about 550 µm long and 50 µm in diameter after 
cell culture for two weeks.[77] Micropatterned scaffolds fabricated from micropatterned templates are also 
potential for engineering of ordered isotropic tissue. For example, 3D scaffolds with large grooves (about 
200 µm wide and 200 µm deep) facilitated the differentiation of myoblasts into myotubes, which were bigger 
and had more cell nuclei compared with those in narrower microgrooves.[78] Micropatterned 
polycaprolactone (PCL) scaffolds could guide the growth of vascular cells but the closed surface pores could 
limit nutrient transfer[79]. Therefore, PLGA micro/nanospheres were used as porogens to generate pores 
significantly smaller than the dimension of microgrooves of PCL scaffolds (48 μm grooves; 5 μm deep; 
12 μm spacing). Both the porous and nonporous micropatterned scaffolds guide the organization of cells 
cultured on them. The porous micropatterned scaffolds had improved medium diffusion which was 6 times 
greater than that of non-porous PCL micropatterned scaffolds. Micropatterned porous scaffolds make it 
possible to engineer 3D organized tissues. 
 
   
1.4.2  The effect of mechanical property 
The mechanical property of scaffolds for cell culture modulates cell behavior. Tissues in human body 
has a wide range of mechanical properties (Table 1.1). Bone tissue as the strongest tissue in the body have a 
compressive strength and modulus up to 300 MPa and 1 GPa for adult femurs. In contrast, skin tissue has a 
soft structure with the indentation modulus of 1-2 MPa. Ideally, scaffolds should have the mechanical 
property similar to the normal tissue to withstand the mechanical loading after implantation. The mechanical 
property of tissues is an important parameter that affects cell-cell interaction and cell phenotype. Scaffolds 
with varied stiffness were used for cartilage tissue engineering to study the effect of scaffold stiffness on 
chondrogenesis. Scaffolds with varied stiffness can be prepared by varying the crosslinking density.[80, 81] 
Soft scaffolds contracted by chondrocytes during cell culture, which reduced the biosynthesis and 
proliferation of cells. Possible mechanisms that explain the reduced cell proliferation are the reduction of 
space for cell growth in the contracted scaffolds, and the stiffness of scaffolds which could affect the cell 
behavior via mechano-transductive pathways.  
Scaffold stiffness could also affect the maintenance of cell phenotype or differentiation of stem cells or 
progenitor cells. A substrate with the stiffness similar to that of specific type of normal tissue could induce 
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the differentiation of stem cells into the specific phenotype of cells in that tissue.[82-84] Some studies 
reported that the contraction of soft scaffolds which increased the cell number density could enhance the 
cell-cell interaction of chondrocytes or stem cells and promote chondrogensis.[85, 86] While substrates of 
varied stiffness did not affect the differentiation of myoblasts into myotubes, culturing myoblasts on a 
substrate with the stiffness similar to the normal muscle tissue (Young’s modulus, approximately 12 kPa) 
promoted the striation of myosin and actin which indicate greater level of differentiation of myoblasts into 
mature muscle cells.[87, 88] 
 
Table 1.1 The mechanical properties and biochemical compositions of major tissue types.  
Tissue type Modulus Major chemical constituents 
Bone[89] 10 GPa (tensile) Hydroxyapatite, Collagen I 
 8.7 GPa (buckling)  
Cartilage[90-92] 400-800 kPa (compressive) Collagen II, chondroitin sulphate 
Tendon[93] 500-660 MPa (tensile) Collagen I, elastin 
Peripheral nerve[94] 1.3-2.9 Mpa (tensile) Galatocerebroside, cholesterol 
Brain[95, 96] 8-15 kPa (sheer)  
Muscle[97] 25-100 kPa (indentation) Myosin, laminin, collagen IV 
Skin[98] 1-2 MPa (indentation) Collagen I, keratin, collagen IV 
 
1.4.3  The effect of chemical composition  
The chemical composition of scaffolds can greatly affect the behavior of cells cultured within the 
material. Cell adhesion and spreading are usually promoted by the use of natural polymer-based scaffolds 
compared with synthetic polymer-based scaffolds which usually have hydrophobic surface. Cells in normal 
tissue are usually surrounded with ECM which serve as a substrate to modulate cell behavior. ECM of 
normal tissue has multiple components such as collagen, laminin, aggrecan, hyaluronic acid, and fibronectin. 
Scaffolds with a chemical composition similar to that of normal tissue ECM could benefit cell growth or 
tissue formation.[99] However, studies also shown that scaffolds with the chemical composition that mimic 
the mature cartilage tissue (abundant of collagen II and aggrecan) inhibited the formation of cartilage tissue. 
Instead, the scaffolds with the chemical composition that mimic the early-stage of cartilage development 
(moderate amount of type II collagen and aggrecan) can promote chondrogenesis.[100] 
Different component of ECM can have different effect on cell behavior. Type I collagen were found to 
promote the tubule formation of endothelial cells while laminin-1 did not.[101] Scaffolds with different 
components of ECM affect the engineering of skeletal muscle tissue. When type I collagen, fibrin and 
Matrigel (a protein mix containing collagen IV, laminin and proteoglycans; produced from culturing mouse 
sarcoma cells) were used to form scaffolds to engineer skeletal muscle, higher composition of fibrin and 
Matrigel yielded greater force generation by engineered muscle tissue and more tissue hypertrophy.[102] 
Collagen substrates and laminin substrates were used to culture myoblasts and the latter significantly 
promoted the cell replication.[103] 
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Although ECM components such as collagen, hyaluronic acid (HA) are normally bioactive polymers 
that favor cell growth or tissue formation, the effect of each component on varied types of cells can be 
dramatically different. HA, the polysaccharide of normal skin ECM, incorporated in collagen scaffolds 
promoted the proliferation of dermal fibroblasts and synthesis of collagen matrix.[104-107] However, HA 
incorporated into collagen scaffolds can have an inhibition effect on the chondrogenic behavior of articular 
chondrocytes.[37] 
Almost all synthetic polymer-based scaffolds cause inflammatory responses such as FBR after their 
implantation into animal. The FBR results formation of a fibrous capsule (usually exceeds 100 µm) that 
isolate the graft from the host tissue, limit the mass transfer between the graft and the host tissue and blood 
vessel formation. Attempts have been made to alleviate the FBR by coating synthetic polymer scaffolds 
(PLGA) with natural ECM such as collagen or porcine small intestinal submucosa (SIS).[108] Implantation 
of these modified scaffolds inhibited the FBR in vivo in a short term. However, after the 
remodeling/degradation of natural ECM coating on the implanted scaffolds, there is still the risk of FBR.  
 
1.5  Thesis motivation, objectives and outline 
1.5.1 Motivation and objectives 
Compared with synthetic polymer scaffolds, natural polymer scaffolds showed advantages such as high 
compatibility with various types of cells and tissues, and mimicking the microenvironment of cells in normal 
tissue. Synthetic polymer scaffolds lack the surface ligands that can be recognized by cells to modulate cell 
behavior. Moreover, synthetic polymer based implant and their degradation products usually cause adverse 
inflammatory responses. In contrast, natural polymers such as proteins and polysaccharides of ECM provide 
abundant surface ligands in favor of cell adhesion, proliferation and assembly. The degradation products of 
natural polymer do not cause adverse responses and can be utilized by tissues. Therefore, in this study 
natural polymers are chosen to develop porous scaffolds for tissue engineering. 
One limitation of conventional natural polymer scaffolds prepared from common fabrication techniques 
is their uncontrolled and closed micropore structure, which makes it difficult to seed cells homogeneously in 
a 3D material, exchange of nutrients and metabolic waste and engineer a homogenous tissue. Porous 
scaffolds with homogeneous and open-pore structure are required to engineer 3D tissues such as skin and 
cartilage. 
Another limitation of conventional natural polymer scaffolds is the lack of 3D topographic guidance to 
engineer anisotropic tissues which have aligned cells, vasculature and ECM of ordered structure. Many types 
of tissues such as skeletal muscle, cardiac muscle, peripheral nerve and blood vessel have highly organized 
tissue structure in which the muscle cells, neurons and endothelial cells are well aligned. To engineer these 
anisotropic tissues we need the materials with anisotropic structure to guide the adhesion, growth and 
assembly of cells. Current studies reported the use of 2D substrates with micropatterned natural polymer to 
guide cell orientation to form cell sheets. The cell sheets need to be layered to form thick tissues, which is 
troublesome and could reduce the cell alignment. 3D micropatterned scaffolds are necessary to engineer 3D 
well-ordered tissues with controlled cell orientation. 
In addition, natural polymer porous scaffolds with controlled microstructure could contribute the studies 
of cell-material interaction and cell-cell interaction within a 3D biomimetic environment. Numerous studies 
have reported the effects of 2D substrates modified with natural polymer or the 2D substrates with varied 
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stiffness on cell behavior. However, the 2D substrates cannot provide cells the 3D microenvironment similar 
to that of normal tissue. 3D natural polymer scaffolds with controlled microstructure can provide a suitable 
platform to study the cell-material and cell-cell interactions in 3D biomimetic environment.  
The limitations of conventional natural polymer scaffolds motivate the objectives of this study:  
(1) To fabricate natural polymer scaffolds with controlled homogeneous micropore structure to 
engineer 3D homogeneous cartilage tissue;  
(2) To fabricate natural polymer scaffolds with controlled anisotropic micropatterned structure to 
engineer 3D anisotropic skeletal muscle;  
(3) To use natural polymer scaffolds with controlled microstructures to study cell-cell interactions and 
cell-material interactions such as cell assembly, proliferation and gene expression in 3D material 
environment.  
1.5.2 Outline 
In this study, natural polymer porous scaffolds with controlled microstructures were developed to 
engineer cartilage tissue and skeletal muscle and study the cell-material, cell-cell interactions in 3D culture.  
Chapter 2 describes the preparation of collagen/HA scaffolds with homogeneous pore structure by using 
low molecular weight salts to suppress PIC formation in collagen/hyaluronic acid(HA) suspensions. The 
suppression of PIC formation was studied by using turbidimetry, viscosity measurement and infrared 
analysis. The effects of PIC formation suppression on the morphology and mechanical properties of the 
scaffolds were examined with scanning electron microscopy and compression tests. Collagen/HA scaffolds 
were used to culture human dermal fibroblasts to study the cell proliferation, tissue synthesis and gene 
expression. 
Chapter 3 describes the preparation of homogeneous collagen/HA scaffolds with well-controlled and 
interconnected pore structure to study the effect of high molecular HA on chondrocyte behavior. 
Collagen/HA scaffolds were prepared by suppression of polyion complex formation between collagen and 
HA and using ice particulates as porogen. Bovine articular chondrocytes were cultured in collagen/HA 
scaffolds and collagen scaffolds to compare the cell proliferation, sGAG synthesis and tissue formation in the 
two types of scaffolds. 
Chapter 4 describes the preparation of gelatin porous scaffolds with homogeneous and open pores to 
engineer cartilage tissue in vitro. Gelatin scaffolds were prepared by using ice particulates and freeze-drying. 
Varied ratios of ice particulates and varied concentrations of gelatin were used to control the micropore 
structure and mechanical property of gelatin scaffolds. The scaffolds were used to culture bovine articular 
chondrocytes to investigate the influence of micropore structure and mechanical property of gelatin porous 
scaffolds on the functions of chondrocytes. 
Chapter 5 describes the development of 3D porous collagen scaffolds with anisotropic and concave 
microgrooves to engineer skeletal muscle tissue. Micropatterned ice lines were used to control the 
micropatterned structure of collagen scaffolds. The microgrooved collagen scaffolds were used to culture rat 
skeletal myoblasts to study the effect of microgroove structure on the assembly of myoblasts into muscle 
tissue. 
Chapter 6 compares the cell behaviors of cocultured myoblasts and vascular endothelial cells in 
microgrooved collagen scaffolds with those in non-paterned collagen porous scaffolds and flat collagen 
scaffolds. The two types of cells were seeded at varied ratios and concentrations in collagen scaffolds to 
study the cell-assembly and formation of anisotropic vascularized muscle tissue. 
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Chapter 7 gives of the conclusions supported by this thesis and suggests the future work. 
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Preparation of highly active porous scaffolds of collagen and 
hyaluronic acid by suppression of polyion complex formation 
 
 
 
 
2.1 Summary 
Collagen-hyaluronic acid scaffolds with high bioactivity, good mechanical property and homogeneous 
pore structures are desirable for their applications in tissue engineering. However, in aqueous condition 
collagen and hyaluronic acid form polyion complexes (PIC), which results in heterogeneous structures and 
poor mechanical properties of the scaffolds. In this study, we used low molecular weight salts to suppress 
PIC formation in collagen-hyaluronic acid suspensions during scaffold preparation. The suppression of PIC 
formation was studied by using turbidimetry, viscosity measurement and infrared analysis. The effects of 
PIC formation suppression on the morphology and mechanical properties of the scaffolds were examined 
with scanning electron microscopy and compression tests. PIC formation was found to be dependent on the 
ionic strength of the suspension. The secondary structure of collagen was partially altered by its strong 
electrostatic interactions with hyaluronic acid. The suppression of PIC formation resulted in 
collagen-hyaluronic acid scaffolds with homogeneous pore structures and remarkably enhanced mechanical 
properties. Collagen-hyaluronic acid scaffolds prepared under suppression of PIC formation promoted 
proliferation of fibroblasts and upregulated the expression of genes encoding EGF, VEGF and IGF-1. Using 
low molecular weight salts to suppress PIC formation could aid in the design of collagen-glycosaminoglycan 
scaffolds for tissue engineering. 
2.2 Introduction 
Three-dimensional porous scaffolds used in tissue engineering act as temporary templates to guide cell 
ingrowth and tissue regeneration. Apart from the requirements of good biocompatibility and nontoxicity, 
scaffolds should have an appropriate pore structure to facilitate cell infiltration and metabolite exchange and 
robust mechanical properties that allow them to endure cell-mediated contraction[1] during cell culture and 
mechanical load at the transplantation site. Ideally, porous scaffolds should mimic the chemical composition 
of native tissue and provide suitable mechanical, structural and biological signals to enhance cell activity and 
tissue regeneration.  
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Collagen-glycosaminoglycan (CG) scaffolds, whose components are the major structural proteins and 
polysaccharides found in a natural extracellular matrix, are widely used in tissue engineering due to their 
good biocompatibility and non-toxic degradation products. Improvements in the biofunctionality and 
regeneration capacity of collagen-derived scaffolds can be achieved through the incorporation of 
glycosaminoglycan[2, 3] and CG scaffolds have been used for the regeneration of various tissues such as 
skin, tendon, nerve, conjunctiva, cartilage and bone[4-8]. However, CG scaffolds prepared by freeze-drying 
CG slurries have inadequate mechanical properties[9, 10] and uneven matrix distribution, which may limit 
their practical use, particularly for applications in load-bearing tissues such as cartilage and bone. Attempts 
to improve the mechanical properties of CG scaffolds have been made by increasing the concentrations of 
collagen and glycosaminoglycan in the CG slurry. However, high CG concentrations result in a 
heterogeneous microstructure[10, 11] due to the heterogeneity of the CG suspension. New methods to 
prepare CG scaffolds with high bioactivity, good mechanical properties and homogeneous pore structures are 
necessary. 
In this study, we used low molecular weight (MW) salts to prepare homogeneous collagen-hyaluronic 
acid (CH) suspensions for scaffold fabrication. The formation of polyion complex (PIC) between positively 
charged collagen and negatively charged hyaluronic acid was suppressed by the salts in the CH 
suspensions[12], making these CH suspensions homogeneous. We hypothesize that PIC suppression in CH 
suspensions will improve the pore structure, mechanical properties and bioactivity of CH scaffolds. 
Therefore, the objective of this research is to study PIC formation in CH suspensions with different 
concentrations of salts and the effects of PIC suppression on the pore structure, mechanical property and 
bioactivity of CH scaffolds. 
2.3 Materials and methods 
2.3.1 Preparation of CH suspensions  
An aqueous solution (pH = 3.0) of type I collagen (1 wt.%) isolated from porcine skin (Nippon Meat 
Packers, Inc.) and an aqueous solution of hyaluronic acid (HA) (1 wt.%) isolated from rooster comb (Wako 
Pure Industries, Ltd.) were used to prepare aqueous suspensions of collagen-hyaluronic acid (CH) mixture. 
Before the two solutions were mixed, sodium chloride (NaCl) granules were added to the collagen and HA 
aqueous solutions, and the solutions were gently stirred at 4 ºC for 12 h. The collagen and HA aqueous 
solutions were then mixed at a volume ratio of 9:1 (collagen:HA) and gently stirred at 4 ºC for 24 h. The 
mixed aqueous suspensions and subsequently freeze-dried samples were designated as CHx, with x 
representing the NaCl concentration (x = 0.000-0.200 M). To study the relationship between ionic strength 
and PIC formation by turbidimetry, we also prepared CH suspensions with a divalent salt (sodium sulfate, 
Na2SO4) at various concentrations. The ionic strength was adjusted to be equivalent to that of NaCl. 
2.3.2 Turbidimetry and viscosity measurements  
The transmittance of the CH mixture aqueous suspensions at 500 nm with different concentrations of 
NaCl and Na2SO4 was measured using an UV-Vis spectrophotometer (V-660, JASCO, Inc.). The sheer 
viscosity of the CH suspensions (within the sheer-speed range of 1-1000 s-1) was recorded at 4 ºC by a 
MCR301 Rheometer and RheoPlus software (Anton Paar Co.). To observe the gross appearance of PIC, CH 
suspensions were centrifuged at a speed of 15,000 rpm at 4 ºC for 30 min to precipitate the PIC in these 
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suspensions. 
2.3.3 Preparation of CH scaffolds  
CH porous scaffolds were prepared by freeze-drying. First, a CH suspension was poured into a silicone 
frame on a copper plate wrapped with perfluoroalkoxy (PFA) film (Universal Co., Ltd). Copper plates were 
chosen as substrates to facilitate heat conduction and PFA film was used to ensure the easy detachment of 
frozen suspensions. A silicone frame (60 mm × 40 mm × 5 mm) on the copper plate was used to confine the 
suspension to the copper plate and control the thickness. The surface of the suspension was flattened by 
covering the silicon frame with a glass plate wrapped in PFA film. The entire construct was then frozen at 
-30 ºC for 9 h. After glass plate and copper plate were removed from the construct, the frozen construct was 
freeze-dried under a vacuum of less than 5 Pa with a freeze dryer (FDU-2200, Tokyo Rikakikai Co., Ltd.) for 
24 h. All samples were frozen and freeze-dried under the same conditions. The non-crosslinked CH scaffolds 
were used for infrared spectrum measurements, while crosslinked CH scaffolds were used for other 
experiments.  
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Peptide Institute, Inc.) and 
N-hydroxysuccinimide (NHS, Wako Pure Chemical Industries, Ltd.) were used as crosslinking agents. EDC 
and NHS were dissolved in an ethanol/water (80/20, v/v) mixture, which was used to protect the CH 
scaffolds from dissolution during crosslinking. A crosslinking solution containing 50 mM EDC and 20 mM 
NHS was prepared. CH scaffolds were kept in the crosslinking solution at room temperature for 8 h. The 
crosslinked scaffolds were washed with MilliQ water for five times. The scaffolds were then soaked in 
MilliQ water, frozen and freeze-dried again under the same previous conditions.  The CH porous scaffolds 
prepared with 0.000, 0.025, 0.050, 0.075, 0.100, 0.125, 0.150 and 0.200 M NaCl were referred as CH0, 
CH0.025, CH0.050, CH0.075, CH0.100, CH0.125, CH0.150 and CH0.200, respectively. 
2.3.4 Infrared analysis  
The infrared spectra of non-crosslinked CH0, CH0.050, CH0.100 and CH0.150 scaffolds were obtained 
using a Fourier transformed infrared spectrometer (FTIR-8400S, Shimadzu Corp.) at a resolution of 4 cm-1. 
For each scaffold, spectra from six different locations were recorded and averaged. Two-dimensional 
infrared correlation spectroscopy (2D-IR) was used to study the changes in molecular conformation. Using 
correlation analysis, 2D-IR can enhance the resolution of an IR spectrum by spreading overlapped IR peaks 
along two dimensions[13] and 2D-IR has been used to analyze the secondary structures and denaturation of 
proteins[14-16]. Under an external perturbation of a system (chemical, electrical, thermal, mechanical 
stimulation, etc.), a sequential set of dynamic IR spectra can be collected and transformed into a 2D 
correlation map to reveal any spectral changes induced by the perturbation. The 2D-IR map, on which 
correlation intensity is plotted as a function of two independent wavenumbers, shows peaks corresponding to 
the structural change caused by the perturbation. Before two-dimensional correlation analysis, the baselines 
of averaged spectra of different CH scaffolds were corrected. These spectra were then analyzed using a 2D 
Pocha software provided by Daisuke Adachi (Kwansei Gakuin University) to generate 2D-IR maps for 
interpretation.  
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2.3.5 Scanning electron microscopy (SEM) and compression tests  
Crosslinked CH scaffolds were cut with a blade and their cross sections were sputter-coated with 
platinum. The cross sections were observed at 10 kV with a scanning electron microscope (JSM-5610, JEOL, 
Ltd.). For compression testing, crosslinked CH scaffolds were cut into disks with a diameter of 8 mm and a 
height of 4 mm using a biopsy punch. The dry disk samples were compressed at a rate of 0.1 mm/s to 
generate stress-strain curves with a texture analyzer (TA.XTPlus, Texture Technologies Corp.). The Young’s 
modulus was calculated from the initial linear region of the stress-strain curve and sample dimension. A 
minimum of six samples were tested for each type of scaffold. 
2.3.6 Culture of dermal fibroblasts in CH scaffolds 
The CH0 and CH0.150 scaffolds were used for culture for human dermal fibroblasts. Collagen porous 
scaffolds prepared by the same procedure as that of CH0 scaffolds were used as a control. The three types of 
scaffolds were punched into disks with a diameter of 12 mm and cut to a thickness of 2 mm. The discs were 
sterilized with 70% ethanol for 30 minutes, rinsed three times with sterile Milli-Q water and conditioned 
with culture medium. Neonatal human dermal fibroblasts (NHDF, Cascade Biologics, Inc.) were subcultured 
in 75-cm2 tissue culture flasks in Medium 106 (Life Technologies Corporation) supplemented with low 
serum growth supplement kit (Life Technologies Corporation) in an incubator equilibrated with 5% CO2 at 
37°C. The adjusted medium was referred as serum medium. The fibroblasts in confluence were rinsed with 
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer, detached from the culture flasks 
using 0.025% (w/v) trypsin and 0.01% (w/v) ethylenediaminetetraacetic acid (EDTA), and neutralized by 
HEPES solution containing 10% FBS (Kurabo Industries, Ltd.). The collected cell suspension was 
centrifuged and suspended in the serum medium to a concentration of 5.0 × 106 cells/ml. The cells were then 
seeded in the three types of scaffolds placed in the wells of 12-well cell culture plates by dropping 200 µl of 
cell suspension solution onto the top surface of each scaffold and cultured in an incubator equilibrated with 
5% CO2 at 37°C. After 3 h incubation to allow cell attachment, 10 mL serum medium was added to each 
well of the plates and cultured for 14 days with the serum medium in an incubator equilibrated with 5% CO2 
at 37°C. The medium was exchanged every two days.  
2.3.7 Analysis of cell distribution and viability 
After 24 hours, 7 days or 14 days of culture, the scaffolds were washed three times with PBS and fixed 
with 2.5% glutaraldehyde aqueous solution at room temperature for 1 hour. The scaffolds were then washed 
three times with pure water, frozen at -30 ºC and freeze-dried for 2 days. The cross sections of the 
freeze-dried samples were coated with platinum for SEM observation to examine cell distribution in the 
scaffolds. 
Live/dead staining was performed to evaluate cell viability using calcein-AM (live: green) and propidium 
iodide (dead: red) staining reagents (Cellstain Double Staining Kit, Dojindo Laboratories). After two weeks 
of culture, the cell/scaffold constructs were washed with HEPES buffer and incubated in 2 µM calcein-AM 
and 4 µM propidium iodide solution in HEPES buffer for 30 minutes. After being rinsed with HEPES buffer, 
the submerged specimens were observed with a fluorescence microscope. 
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2.3.8 Cell proliferation assay and real-time PCR analysis 
The cell proliferation in the scaffolds was evaluated by quantifying the DNA amount. After being 
cultured for 1, 3, 7, or 14 days, the cell/scaffold constructs were washed with pure water, freeze-dried and 
then digested with papain solution. Papain (Sigma-Aldrich, St Louis, Missouri, USA) was dissolved at 400 
µg/ml in 0.1 M phosphate buffer (pH 6.0), with 5 mM cysteine hydrochloride and 5 mM 
ethylenediaminetetraaceticacid (EDTA). An aliquot of papain digests was used to measure the DNA content 
with Hoechst 33258 dye (Sigma-Aldrich) and an FP-6500 spectrofluorometer (JASCO, Tokyo, Japan) at an 
excitation wavelength of 360 nm and emission wavelength of 460 nm. Four samples were used to calculate 
the average and standard deviation. 
For analysis of gene expression, the cell/scaffold constructs (3 samples for each type of scaffolds) after 
the 14-day culture were rinsed with PBS buffer, immersed in 1 ml Sepasol-RNA I Super G solution (Nacalai 
Tesque, Inc.) and frozen at -80 ºC. The frozen constructs were crushed into powder by an electric crusher 
and transferred back into the Sepasol solution to isolate the RNA from the cells. Total RNA (1.0 µg) was 
used as a first strand reaction that included random hexamer primers and murine leukemia virus reverse 
transcriptase (Applied Biosystems, Foster City, CA). Real-time PCR was amplified for 18 S rRNA, 
glyceraldehyde 3 phosphate dehydrogenase (GAPDH), epidermal growth factor (EGF), vascular endothelial 
growth factor (VEGF) and insulin-like growth factor-1 (IGF-1). The reaction was performed with 10 ng of 
cDNA, 90 nM PCR primers, 25 nM PCR probe, and FastStart TaqMan Probe Master (Roche Diagnostics 
Japan, Tokyo, Japan). The expression levels of 18 S rRNA were used as an endogenous control, and gene 
expression levels relative to GAPDH were calculated using the comparative Ct method. The sequences of 
primers and probes are listed in Table 1. The primers and probes were obtained from Applied Biosystems 
and Hokkaido System Science (Sapporo, Japan). 
 
Table 1. Primers and probes for real-time PCR analysis. 
mRNA Oligonucleotide 
18 S rRNA 
GAPDH 
VEGF 
EGF 
IGF-1 
Hs99999901_s1 
Hs99999905_m1 
Hs00900054_m1 
Hs00153181_m1 
Hs00153126_m1 
2.3.9 Statistical analysis  
A one-way analysis of variance followed by pairwise multiple comparison (Tukey Test) was used to 
compare groups of data. Paired t-tests were used to compare individual sets of data. Significant differences 
were considered when p < 0.05. 
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2.4 Results and discussion 
2.4.1 PIC formation and turbidity of CH suspensions  
Collagen and HA aqueous solutions were mixed with or without salts to prepare the CH aqueous 
suspensions. Two kinds of low molecular weight salts, NaCl and Na2SO4, were used to prepare the CH 
suspensions for the study of the relationship between ionic strength and PIC formation. By gross observation, 
the CH suspensions prepared without salt (CH0) were opaque. CH suspensions prepared with 0.100 M NaCl 
(CH0.100) were semitransparent, while CH suspensions prepared with 0.200 M NaCl (CH0.200) were clear 
(Fig. 2.1a). The CH0, CH0.100 and CH0.200 suspensions were centrifuged to further reveal the PIC 
formation in different CH suspensions. After centrifugation, the PIC in CH0 settled at the bottom of tube and 
was white and compact in appearance. The PIC in CH0.100 was watery and loose, while no obvious PIC 
sediment was observed in CH0.200 (Fig. 2.1b). The transmittance of the CH suspensions was measured after 
the suspensions were prepared at ionic strengths of 0.000 to 0.200 M (Fig. 2.1c, d). Despite the different salts 
used, the transmittance of CH suspensions remained approximately zero at low ionic strengths, increased 
gradually as the ionic strength increased and increased rapidly when the ionic strength changed from a 0.100 
M to 0.150 M, after which the maximum transmittance was maintained.  
With the presence of salts in the CH suspensions, PIC formation between collagen and HA was 
suppressed due to the ability of cations and anions from low MW salt to screen the charges along the 
polymer chains. The suppression of PIC formation by different concentrations of salts resulted in the 
different transparencies observed in the CH suspensions. When CH suspensions were prepared without salts 
or with a low concentration of salt, PIC formed and the suspension was opaque, resulting in low 
transmittance. When high concentrations of salts were used, PIC formation was suppressed and the CH 
suspensions were clear, resulting in high transmittance. The similarity between the two transmittance curves 
of CH suspensions prepared with monovalent salts (NaCl) or divalent salts (Na2SO4) indicates that PIC 
formation was dependent on the ionic strength of the CH suspensions rather than the type of salt used, which 
is consistent with previous studies on PIC formation and ionic strength[17-19]. Therefore, only NaCl was 
used for the following experiments. 
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Fig. 2.1. Formation of polyion complex in CH suspensions. Gross appearance of (a) CH suspensions with 
different concentrations of NaCl (0, 0.100 or 0.200 M NaCl) and (b) CH suspensions after centrifugation. 
Arrows mark the boundary between the precipitated PIC and supernatant. Transmittance at 500 nm of CH 
suspensions prepared with different concentrations of (c) monovalent NaCl or (d) divalent Na2SO4.The ionic 
strength (M) was calculated from molar concentrations of salt ions. (e) Sheer viscosity-sheer speed 
relationship of CH suspensions prepared with different concentrations of NaCl (0 - 0.200 M). (f) Viscosities 
of CH suspensions measured at a sheer speed of 10 s-1. Means ± SD, N = 3. 
 
2.4.2 Viscosity of CH suspensions  
The sheer viscosity of CH suspensions prepared with different NaCl concentrations was measured, as 
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shown in Fig. 2.1e, f. All CH suspensions were sheer-thinning: their viscosity decreased with increasing 
sheer speed. The viscosities of the CH suspensions prepared without NaCl or with 0.050 M NaCl were the 
lowest of those measured. The viscosity increased when the NaCl concentration increased from 0.050 M to 
0.120 M, and remained unchanged after the NaCl concentration reached 0.125 M. 
The observed variations in viscosity can be explained by the electrostatic interactions between collagen 
and HA molecules in suspension. When the positively charged collagen and negatively charged HA 
interacted, they formed PIC. The binding affinity between collagen and HA molecules was weakened by the 
presence of Na+ and Cl- ions in the suspensions. With no NaCl or low concentrations of NaCl (< 0.100 M), 
ionic strength was too low to shield the charges on collagen and HA polymer chains and to weaken their 
strong binding affinity, resulting in the formation of compact PIC. The formation of compact PIC resulted in 
decrease of soluble polymer molecules in the suspension and therefore a low viscosity. At intermediate NaCl 
concentrations (0.100 – 0.125 M), the collagen and HA polyions were partially shielded by Na+ and Cl- ions, 
weakening the binding affinity between the polyions. A weak binding affinity resulted in loose PIC that was 
not completely separated from the suspension and therefore viscosity of median values. The viscosity 
increased with NaCl concentration and peaked at high NaCl concentrations (≥ 0.150 M), where the polyions 
were completely shielded by their counterions and PIC formation was suppressed. Therefore, viscosity 
reached a stable maximum.  
2.4.3 Infrared analysis  
To examine the effects of the addition of salt on the molecular structures of collagen and HA, we 
analyzed the infrared spectra of non-crosslinked CH sponges prepared from CH suspensions with different 
NaCl concentrations (Fig. 2.2a). Non-crosslinked CH sponges, prepared by freeze-drying CH suspensions, 
were used for IR analysis to eliminate any effects from the crosslinking reagent. No obvious differences 
among these spectra were observed because of the same functional groups of collagen and HA in all of the 
sponges.  
The 2D-IR map was used to elucidate the structural change of collagen and HA molecules in CH 
scaffolds caused by the addition of varying amounts of NaCl. A sequential set of spectra of non-crosslinked 
CH sponges (CH0, CH0.050, CH0.100, CH0.150) was used for 2D-IR analysis to generate the synchronous 
2D-IR maps (Fig. 2.2b, c). The autopeak (autopeaks: peaks located on the diagonal line) at 1655 cm-1 
denoted a shift of the amide I band, indicating that collagen had a partially unordered structure at low NaCl 
concentrations while maintained its α helical structure at high NaCl concentrations. This suggests that the 
strong electrostatic interactions between collagen and HA molecules in suspensions without NaCl or with 
low NaCl concentrations could disturb the triple helical structure of collagen. The autopeaks at 3346 cm-1 
and 1552 cm-1 demonstrated that N—H stretching and N—H bending were stronger at higher NaCl 
concentrations. The more intense stretching and bending vibrations of the amine groups suggested that 
collagen and HA molecules were less complexed at higher NaCl concentrations. The loss of α helical 
structure or the increase of unordered structure in proteins interacting with polyions has also been reported in 
previous works [20-22].  
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Fig. 2.2. (a) IR spectra of non-crosslinked CH sponges prepared from CH suspensions with different NaCl 
concentrations (0, 0.050, 0.100 or 0.150 M NaCl). (b and c) Synchronous 2D-IR maps of non-crosslinked 
CH sponges prepared from CH suspensions with different NaCl concentrations. The upper right zone 
(1500-1775 cm-1) of (b) is magnified and shown in (c). The one-dimensional spectra on the top and right 
columns of the maps are the average spectra used in the correlation analysis.  
2.4.4 Scaffold morphology  
Fig. 2.3 displays the SEM images of the microstructures of the crosslinked CH scaffolds. Crosslinked 
CH sponges exhibited flake-like microstructures. There were some matrix blocks indicated by arrows and 
fibers indicated by arrowheads in the images of CH0, CH0.025, CH0.050 and CH0.075 CH scaffolds. The 
blocks were polymer matrix-rich regions with a high polymer density, while the fibers were polymer 
matrix-poor regions with a low polymer density. When NaCl concentrations were lower than 0.075 M, CH 
scaffolds exhibited heterogeneous pore structures with an unevenly distributed polymer matrix. Scaffolds 
prepared at intermediate or high NaCl concentrations (≥ 0.100 M) showed well-ordered micropore structures 
and an even distribution of polymer matrix. 
 
Fig. 2.3. SEM images of cross sections of crosslinked CH scaffolds prepared with different concentrations of 
NaCl (0 - 0.200 M). The arrows indicate the regions of high polymer density, and the arrowheads indicate 
the regions of low polymer density. Scale bar = 100 μm. 
 
The scaffold morphology was consistent with PIC formation as examined in previous parts. The 
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compact PIC that formed without NaCl or at low NaCl concentrations resulted in the local condensation of 
the polymer matrix and a heterogeneous pore structure. The blocks CH0, CH0.025, CH0.050 and CH0.075 
CH scaffolds should be due to the PIC in the CH suspensions which resulted in generation of polymer 
matrix-rich and poor regions. However, at higher NaCl concentrations, either PIC became loose or no PIC 
formed. The CH suspensions without PIC or with loose PIC avoided the local condensation of polymer 
matrix, resulting in the even distribution of polymer matrix and a homogeneous pore structure.  
Previous studies by Harley et al.[10] and Davidenko et al.[11] reported that a high concentration (≥ 1 
wt.%) of collagen and GAG suspension for scaffold preparation would result in heterogeneous CG scaffolds. 
This was confirmed by the heterogeneous morphology of CH0 scaffolds in our study. With the addition of 
NaCl to suppress PIC formation, a homogenous distribution of polymer matrix could be achieved. Apart 
from NaCl, other low molecular weight salts such as KCl and Na2SO4 can be used. Therefore, the difficulty 
in preparing homogeneous CG scaffolds from highly concentrated suspensions can be overcome by 
suppressing the PIC formation using low MW salts.  
2.4.5 Mechanical property 
The compressive Young’s modulus of the crosslinked CH scaffolds prepared with different 
concentrations of NaCl was measured through compression tests and the results are shown in Fig. 2.4. The 
compressive modulus increased with NaCl concentration and reached a plateau when the NaCl concentration 
was higher than 0.100 M. The modulus of a CH scaffold prepared with 0.100 M NaCl was approximately 
5-fold higher than that of a CH0 scaffold. The higher mechanical properties of CH scaffolds prepared with 
high concentrations of NaCl (0.100 - 0.200 M) might result from the homogeneous pore structure of these 
scaffolds. In contrast, the CH scaffolds prepared without NaCl or low NaCl concentrations showed 
heterogeneous pore structures and had lower mechanical strength. The correlation between improved 
mechanical property and a well-defined pore structure in porous scaffolds has also been previously 
reported[23-25].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.4. Compression moduli of crosslinked CH scaffolds prepared with different concentrations of NaCl (0 
- 0.200 M). Mean ± SD, N =6; **, p<0.01; NS, no significant difference. 
 
After examining the PIC formation in CH suspensions and the properties of scaffolds from these 
suspensions, we proposed a mechanism to explain the formation of PIC at different ionic strengths and its 
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effects on the morphology and mechanical properties of scaffolds. The interactions between the polyions 
(collagen and HA) and the different states of PIC formed under different ionic strengths are illustrated in Fig. 
2.5. Because the binding affinity of collagen and HA molecules was determined by the ionic strength of the 
aqueous environment, polyions of opposite charges are compactly complexed at a low ionic strength (Fig. 
2.5a), or become loosely complexed at an intermediate ionic strength (Fig. 2.5b) but no complexes are 
formed at high ionic strengths (Fig. 2.5c). Compact PIC in CH suspensions interferes with the polymer 
diffusion during the solidification of the CH suspensions at a low temperature, which renders the network of 
polymer solids heterogeneous. CH suspensions with loose PIC or no PIC are able to undergo even polymer 
diffusion that results in a homogeneous polymer matrix network. The homogeneous micropore structure and 
the uniform distribution of collagen and HA within the matrix may account for the improved mechanical 
properties of CH scaffolds. 
 
Fig. 2.5. Speculated schema of (a) compact PIC, (b) loose PIC and (c) no PIC formation in CH suspensions 
at different concentrations of salt. The solid arrows indicate complete complexation of collagen and HA, and 
the dashed arrows indicate partial complexation of collagen and HA. 
 
2.4.6 Cell adhesion and proliferation in CH scaffolds 
Adhesion of fibroblasts in the scaffolds after culture for 24 hour was observed by using SEM. 
Fibroblasts adhered to all the three types of scaffolds and showed better spread in the CH0.150 than  
did in CH0 and Col scaffolds (Fig. 2.6a). The cell proliferated with culture time and filled the spaces in the 
scaffolds (Fig. 2.6b-d). Most of the cells were alive and few dead cells were detected (Fig. 2.6e). DNA 
Quantification (Fig. 2.7) showed that the DNA content in the three types of scaffolds was almost the same 
after one day culture and increased with culture time. The increase of DNA content in the three scaffolds 
with culture time was in the increasing order of Col<CH0<CH0.15. DNA content in the CH0.15 scaffold 
after 14 days culture was significantly higher than that in the Col and CH0 scaffolds. The results indicated 
that CH0.15 scaffold had a higher promotive effect on the proliferation of fibroblasts compared to Col and 
CH0 scaffolds. 
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Fig. 2.6. (a) Adhesion of NHDFs in Col, CH0, and CH0.15 scaffolds after culture for 24 hours. Arrows mark 
some of the fibroblasts adhered on the walls of scaffolds. (b-d) SEM images showing proliferation of NHDFs 
and production of ECM during the 14 days culture. (e) Live/dead staining of NHDFs in collagen (Col), CH0, 
and CH0.15 scaffolds after culture for the 14 days. Green: live cells; red: dead cells.  Scale bars, a: 20 μm; 
b-d: 100 μm; e: 200 μm. 
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Fig. 2.7. Proliferation of NHDFs in Col, CH0, and CH0.15 scaffolds during the 14 days culture, as 
determined by DNA quantification. Mean ± SD, N = 4; **, p<0.01; NS, no significant difference. 
 
Fig. 2.8. Gene expression levels of NHDFs cultured in Col, CH0, and CH0.15 scaffolds for 14 days; the 
NHDFs used for cell seeding at day 1 were used as control group. EGF: epidermal growth factor; VEGF: 
vascular endothelial growth factor; IGF-1: insulin-like growth factor 1. Mean ± SD, N =3; *, p<0.05; ***, 
p<0.001; #, p<0.05, compared to Control; ##, p<0.01, compared to Control; ###, p<0.001, compared to 
Control. 
 
The expression of genes encoding EGF, VEGF and IGF-1 was analyzed after 14 days culture (Fig. 2.8). 
Fibroblasts cultured in the CH0.15 scaffold showed the highest expression of these genes. The cells cultured 
in the CH0 scaffold showed higher expression level of these genes than did in the Col scaffold. These results 
indicated that the CH scaffolds promoted cell proliferation and expression of the genes encoding EGF, 
VEGF and IGF-1. The results were in good agreement with previous reports that show that CH scaffolds 
have a promotive effect on cell proliferation [11, 26]. Cell proliferation was further promoted and the 
expression of EGF, VEGF and IGF-1 was upregulated when fibroblasts were cultured in the CH0.15 scaffold. 
Suppression of PIC formation during the scaffolds preparation could make the homogeneous distribution of 
HA in collagen matrix and maintain collagen’s secondary structure, which therefore stimulated cell 
proliferation in the porous matrices at the highest level. High expression of EGF, VEGF and IGF-1 should 
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have some effects on the promotion of cell proliferation because these genes have been reported to be 
concerned with proliferation of fibroblasts [27-29]. On the other hand, cells may sense the mechanical 
property of their substrate via the integrin-actin coupling at focal adhesion complexes[30] and adapt their 
behaviors such as adhesion and proliferation to different scaffold stiffness[31, 32]. Therefore, the high 
mechanical property of CH0.15 scaffold might also have promoted the proliferation of fibroblast through 
mechano-transduction pathways. 
2.5 Conclusions 
The interactions between collagen and hyaluronic acid in suspensions of various ionic strengths were 
examined with turbidimetry and viscosity measurements. Gross appearance observations and turbidimetry 
showed that PIC formation between collagen and HA was dependent on the ionic strength of their 
suspension. Viscosity measurements further confirmed the different states of PIC formed under various ionic 
strengths. The strong binding affinity of collagen and HA can partially induce a change in collagen’s 
secondary structure, as indicated by infrared analysis. The effects of PIC suppression by low molecular 
weight salts on the morphology and mechanical properties of CH scaffolds were examined with SEM and 
compression tests. CH suspensions with no PIC or loose PIC resulted in scaffolds with homogeneous 
micropore structures and markedly improved compressive moduli, compared with those fabricated from CH 
suspensions with compact PIC. CH scaffolds prepared with no PIC promoted proliferation of fibroblasts and 
expression of EGF, VEGF and IGF-1 genes. Using low molecular weight salts to suppress PIC in CG 
suspensions used to prepare scaffolds should aid in the design of highly active CG scaffolds with 
homogeneous pore structures and good mechanical properties for tissue engineering. 
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Effect of high molecular weight hyaluronic acid on chondrocytes 
cultured in collagen/hyaluronic acid porous scaffolds 
 
 
 
 
3.1 Summary 
Engineering cartilage tissue by culturing chondrocytes in porous scaffolds is one promising method to 
repair or restore the functions of diseased cartilage. Hyaluronic aid (HA) was used in porous scaffolds or 
hydrogels to promote the proliferation of chondrocytes and synthesis of cartilage extracellular matrix (ECM). 
However, whether HA in scaffolds has a beneficial effect on chondrocytes remains uncertain, possibly due to 
the uncontrolled pore structure and inhomogeneous HA in scaffolds. In this study, homogeneous 
collagen/HA scaffolds with well-controlled and interconnected pore structure were prepared by suppression 
of polyion complex formation between collagen and HA and using ice particulates as porogen. The pore 
structure and mechanical property of collagen/HA scaffolds and collagen scaffolds could be well controlled. 
High molecular weight HA in collagen/HA scaffolds inhibited the cellular proliferation, synthesis of sulfated 
glycosaminoglycan and cartilage ECM, compared with the results of collagen scaffolds. This study should 
provide additional information on the effects of HA in porous scaffolds on the chondrocyte behavior in 3D 
culture. 
3.2 Introduction 
Human articular cartilage has limited self-repair because of the avascular nature, low rate of 
chondrocyte proliferation and matrix turnover [1-3]. Tissue engineering has been developed to engineer 
cartilage tissue to repair and restore the function of diseased cartilage. In cartilage tissue engineering, 
chondrocytes from the non-load bearing parts of cartilage are isolated, expanded in vitro, seeded in a 
three-dimensional (3D) scaffolds and cultured to engineer cartilage tissue. 3D porous scaffolds can provide 
the space for the adhesion and proliferation of chondrocytes and formation of extracellular matrix of 
cartilage [4-6]. 
Porous collagen scaffolds have been widely used to engineer various types of tissues such as skin, 
muscle and cartilage [7-12]. Collagen scaffolds with a high porosity and good interconnectivity are required 
to enable the homogeneous seeding of chondrocytes in the whole scaffolds and nutrient/oxygen transfer 
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during cell culture. Porous collagen scaffolds can be prepared by using freeze-drying a collagen aqueous 
solution and cross-linking treatment. To enable good interconnectivity of collagen scaffolds, ice particulates 
have been used as porogen which can also initiate ice crystallization during freezing of collagen solution for 
the formation of interconnected pore structure after freeze-drying [13, 14]. 
Hyaluronic acid (HA) is abundant in the synovial fluid which functions to lubricate the surface of 
articular cartilage of joints. HA is also contained in cartilage and low concentrations of HA has important 
biological effects [15, 16]. HA has been used to maintain the phenotype, promote the proliferation of 
chondrocytes and synthesis of cartilage ECM. For example, chondrocytes have been cultured in hydrogels 
that contained HA of different concentrations and the concentration of HA affected the cell proliferation and 
synthesis of aggrecan or chondroitin sulfate[17, 18]. HA has also been supplemented in culture medium to 
culture chondrocytes in hydrogels or porous scaffolds, and HA in the medium affected cell proliferation and 
ECM synthesis in a dose-dependent manner [19, 20]. However, the effects of HA in collagen scaffolds or 
hydrogels remains controversial. While some studies have shown high molecular weight (MW) HA can 
promote the proliferation of chondrocytes and the synthesis of sulfated glycosaminoglycan (sGAG), some 
other studies have shown that high MW HA suppresses the expression of chondrogenesis-related genes such 
as the genes for collagen type II and aggrecan [21-23]. The inhomogeneous HA in scaffolds due to formation 
of polyion complex (PIC) between collagen and HA and uncontrolled pore structure from normal 
freeze-drying might confound the effect of HA on chondrocytes.   
In this study, homogeneous collagen/HA scaffolds were prepared to study the effect of high MW HA on 
the proliferation and ECM synthesis of chondrocytes in 3D culture. Firstly, a homogeneous suspension of 
collagen/HA was prepared by suppression of PIC formation between collagen and HA. Secondly, the 
homogeneous collagen/HA suspension was used in combination with ice particulates to prepare collagen/HA 
scaffolds with well-controlled and interconnected pore structure. Finally, the porous scaffolds were used to 
culture bovine articular chondrocytes and the cell proliferation, ECM synthesis and tissue formation were 
examined to study the effect of high MW HA in collagen scaffolds for cartilage tissue engineering. 
3.3 Materials and methods 
3.3.1 Preparation of porous collagen/HA scaffolds 
An aqueous solution (pH = 3.0) of type I collagen (2 wt.%) from porcine skin (Nippon Meat Packers, 
Inc.) and an aqueous solution of high MW hyaluronic acid (HA) (2 wt.%) from rooster comb (MW, ~ 1 × 106 
Da; Wako Pure Industries, Ltd.) were used to prepare aqueous suspensions of collagen/HA mixture. 10 v.% 
of ethanol was used to dissolve collagen and HA. Before the two solutions were mixed, sodium chloride 
(NaCl) granules were added separately to the collagen and HA aqueous solutions, and the solutions were 
gently stirred at 4 °C for 12 h. The collagen and HA aqueous solutions were then mixed at a ratio of 9 : 1 
(collagen : HA, v/v) and gently stirred at 4 °C for 24 h. Type I collagen (2 wt.%) solution without NaCl 
addition was used to prepare collagen scaffolds. The transmittance of the collagen/HA suspensions at 500 nm 
with different concentrations of NaCl was measured using an UV-Vis spectrophotometer (V-660, JASCO, 
Inc.).  
Collagen/HA scaffolds and collagen scaffolds were prepared by using ice particulates and freeze-drying 
[11]. Briefly, ice particulates were prepared by spraying pure water into liquid nitrogen and sieving to control 
their diameter to 150 - 250 µm. Images of the ice particulates were imported into ImageJ software to 
measure the diameter of ice particulates. Collagen/HA suspension (NaCl concentration: 0.2 M) and collagen 
Effect of high MW HA on chondrocyte behavior in scaffolds 
49 
 
solution were cooled and mixed with pre-prepared ice particulates at the ratio of 1:1 (volume of liquid (ml): 
weight of ice particulates (g)) at -5 °C. The mixtures were transferred into a silicone mold (60 mm × 40 mm 
× 5 mm) on a copper plate wrapped with perfluoroalkoxy (PFA) film (Universal Co., Ltd). The mixture in 
the mold was flattened by covering the silicon frame with a glass plate wrapped with PFA film. The entire 
construct was frozen at -80 ºC for 9 h. After glass plate and copper plate were removed from the construct, 
the frozen constructs were freeze-dried under a vacuum of less than 5 Pa for 24 h by using a freeze dryer 
(FDU-2200, Tokyo Rikakikai Co., Ltd.) to obtain porous scaffolds. The porous scaffolds were crosslinked 
using a solution of 50 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Peptide Institute, Inc.) 
and 20 mM N-hydroxysuccinimide (NHS, Wako Pure Chemical Industries, Ltd.) in an ethanol/water mixture 
(80/20, v/v) for 8 h as reported previously [24]. The crosslinked scaffolds were washed with MilliQ water for 
six times, soaked in MilliQ water, frozen and freeze-dried again under the same conditions.   
3.3.2 Scanning electron microscopy and compression test 
Crosslinked scaffolds were cut with a blade and their cross sections were sputter-coated with platinum. 
The cross sections were observed at 10 kV with a scanning electron microscope (SEM) (JSM-5610, JEOL, 
Ltd.). SEM images were imported in ImageJ software to measure the pore size of scaffolds. Three images of 
each type of scaffolds were imported and at least 60 pores per image were measured. For unconfined 
compression test, crosslinked scaffolds were cut into disks with a diameter of 6 mm and a height of 3 mm 
using a biopsy punch. Mechanical property of scaffolds in dry state and hydrated state were tested. The dry 
scaffolds were immersed in phosphate buffered saline (PBS) for 2 hours at room temperature to get hydrated 
scaffolds. Each sample was placed on the testing platform (Heavy Duty Platform, Stable Micro System) of a 
texture analyzer (TA.XTPlus, Texture Technologies Corp.) and compressed with a 20-mm diameter cylinder 
probe (P/20, Stable Micro System). The compression test started with a trigger force of 0.1 g. Samples were 
compressed at the rate of 0.1 mm/s until reaching 80% strain. Stress and strain values were acquired at the 
sampling frequency of 50 Hz by using a TA.XTPlus software to generate stress-strain curves. Young’s 
modulus was calculated from the initial linear region of the stress-strain curve and sample dimension. A 
minimum of four samples were tested for each type of scaffold. 
3.3.3 Culture of cells in scaffolds 
Bovine articular chondrocytes (BACs) were isolated from the articular cartilage of the knees of 9-week 
old female calves from a local slaughterhouse as reported previously [11]. Cell culture medium was prepared 
from high-glucose Dulbecco’s Modified Eagle’s Medium (D6546, Sigma-Aldrich Co.) supplemented with 
10% fetal bovine serum, 4 mM glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 0.1 mM 
nonessential amino acids, 0.4 mM proline, 1 mM sodium pyruvate and 50 μg/ml ascorbic acid. The primary 
BACs were subcultured in tissue culture flasks with the culture medium. P2 chondrocytes were harvested 
and suspended in the culture medium to get the suspension of BACs (3.33 × 107 cells/ml) for cell seeding.  
Porous scaffolds were punched into disks (6 mm in diameter and 3 mm in thickness), sterilized with 
70(v/v)% ethanol aqueous solution, washed with PBS for 6 times and conditioned with culture medium at 
37 °C for 2 hours. After the culture medium in the scaffold disks was absorbed away using sterilized 
Kimwipe paper, 60 µl of the chondrocyte suspension was pipetted onto each scaffold disk and incubated at 
37 °C. After 3 hours of incubation, the scaffolds were turned upside down and the medium inside was 
absorbed away. Another 60 µl chondrocyte suspension was pipetted onto each scaffold disk and incubated at 
37 °C for 3 hours and culture medium was added. After 1 day culture, all the cell/scaffold constructs were 
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transferred to 25-cm2 tissue culture flasks and cultured in the medium under shaking (60 rpm) for 4 weeks. 
3.3.4 Live/dead staining 
Live/dead staining was performed to evaluate cell viability using calcein-AM and propidium iodide 
staining reagents (Cellstain Double Staining Kit, Dojindo Laboratories). After culture for 1 day, 1 week, 2 
weeks or 4 weeks, the cell/scaffold constructs were washed with PBS and incubated in PBS-diluted 
calcein-AM (2 µM) and propidium iodide (4 µM) for 30 minutes. After being rinsed with PBS, the constructs 
were observed with a fluorescence microscope. 
3.3.5 Quantification of DNA and sGAG and compression test of cultured constructs 
Proliferation of the chondrocytes in scaffolds was evaluated by quantifying the DNA amount as 
described previously [24]. Briefly, cell/scaffold constructs cultured for 1 week, 2 weeks, 3 weeks or 4 weeks 
were harvested, freeze-dried and digested with papain solution. Aliquots of the papain digests were used to 
measure the DNA and sGAG amount of each sample. The DNA amount was quantified by using Hoechst 
33258 dye (Sigma-Aldrich) and an FP-6500 spectrofluorometer (JASCO, Tokyo, Japan). The sGAG content 
was quantified by using Blyscan™ Glycosaminoglycan Assay (Biocolor Ltd., UK) according to the 
manufacturer’s instructions.  
Cell/scaffold constructs cultured for 1 week, 2 weeks or 4 weeks were harvested and kept in culture 
medium before compression test. The compressive modulus of cell/scaffold constructs was determined by 
using the compressive test described above. Four samples were used to calculate the average and standard 
deviation. 
3.3.6 Histological staining  
Cell/scaffold constructs cultured for 4 weeks were washed in PBS and fixed in 10% neutral buffered 
formalin for 2 days at room temperature. The constructs were dehydrated in ethanol series, embedded in 
paraffin and sectioned to get the vertical cross sections of constructs (8-μm thick). The cross sections were 
deparaffinized and stained with hematoxylin/eosin staining or safranin O/light green staining as described in 
previous work [11] . 
 
3.3.7 Statistical analysis 
Student-t test was used to compare two groups of data. Significant differences were considered when p 
< 0.05. 
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3.4 Results and discussion 
3.4.1 Suppression of PIC 
Collagen/HA scaffolds were prepared by suppressing formation of polyion complex (PIC) between 
collagen and HA and using ice particulates as porogen. Before collagen and HA solutions were mixed, 
sodium choloride (NaCl) was added into each solution to increase their ionic strength so that the formation of 
PIC in collagen/HA suspension could be suppressed. Formation of PIC was dependent on the ionic strength 
of collagen/HA suspensions (Fig. 3.1). Collagen/HA suspension without NaCl treatment was opaque due to 
the formation of PIC and the inhomogeneous suspension made it difficult to prepare a homogeneous scaffold. 
Collagen/HA suspensions with a high NaCl concentration (0.20 - 0.30 M) were transparent due to the 
suppression of PIC formation. Sodium and chloride ions in these suspensions shielded the electronic 
interaction of oppositely charged collagen and HA molecules and suppressed the formation of PIC. A 
homogeneous collagen/HA suspension (NaCl concentration = 0.2 M) was chosen to prepare collagen/HA 
scaffolds. Collagen solution without HA was used to prepare collagen scaffolds as the control group. 
 
 
Fig. 3.1. Suppression of polyion complex formation in collagen/HA suspension by adding NaCl. (a) 
Collagen solution and collagen/HA suspensions with different concentration of NaCl ([NaCl] = 0 - 0.3 M). 
(b) Transmittance at 500 nm of collagen/HA suspensions with different concentration of NaCl. Means ± SD, 
N = 3. 
3.4.2 Pore structure and mechanical property 
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Collagen scaffolds and collagen/HA scaffolds had homogeneous, interconnected pore structure which 
were well controlled by using ice particulates and freeze-drying (Fig. 3.2). The ice particulates used to 
prepare scaffolds had the diameter of 179 ± 33 µm. The macropores of collagen scaffolds and collagen/HA 
had the diameter of 172 ± 38 µm and 187 ± 45 µm, respectively, which were controlled by the size of ice 
particulates (Fig. 3.3 and Fig. 3.4). The macropores were interconnected by the micropores due to the ice 
crystallization between neighbouring ice particulates 13. The mechanical property of these scaffolds in dry 
state or hydrated state was quantified using a compression test. The two types of scaffolds in dry state or 
hydrated state had similar compressive moduli (Fig. 3.5). The dry scaffolds had higher compressive moduli 
than hydrated scaffolds. The two types of scaffolds had the same scaffold density (both prepared from 2 
wt.% polymer solution). Collagen scaffolds were prepared from 2 wt.% collagen solution and collagen/HA 
scaffolds were prepared from the solution with 1.8 wt.% collagen and 0.2 wt.% HA. The polymer mass of 
the solutions used to prepare two types of scaffolds was the same.  In addition, the two types of scaffolds 
had similar pore structure which was controlled by using ice particulates as porogen. The similarity in 
scaffold density and pore structure might explain the similar compressive modulus of two types of scaffolds. 
These results showed that the pore structure and mechanical property of two types of scaffolds were 
controlled by using ice particulates as porogen. 
 
Fig. 3.2. SEM images of cross sections of collagen and collagen/HA scaffolds after crosslinking. Scale bar = 
100 µm. 
 
 
Fig. 3.3. Ice particulates with the diameter of 150-250 µm. 
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Fig. 3.4. The pore size of collagen scaffolds or collagen/HA scaffolds, and the diameter of ice particulates 
used for scaffold preparation (µm). Means ± SD, N ≥ 60. There was no significant statistical difference 
among the data of three groups. 
 
Fig. 3.5. Compressive modulus of crosslinked collagen and collagen/HA scaffolds in dry state or hydrated 
state. Means ± SD, N = 4. NS, no significant difference. 
3.4.3 Cell viability 
Bovine articular chondrocytes were seeded in the porous scaffolds to study the effects of high MW HA 
in porous collagen scaffolds on the functions of chondrocytes. Live/dead staining of the cells cultured in the 
collagen and collagen/HA porous scaffolds showed that cell proliferated and maintained a high viability 
during the 4-week culture (Fig. 3.6).  
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Fig. 3.6. Live/dead staining of chondrocytes cultured in collagen and collagen/HA scaffolds for 1 day (1d), 1 
week (1w), 2 weeks (2w) and 4 weeks (4w). Green: live cells; red: dead cells. Scale bar = 200 µm. 
3.4.4 Proliferation, sGAG synthesis of cells and mechanical property of tissue 
The proliferation of chondrocytes in the porous scaffolds was measured using DNA quantification (Fig. 
3.7a). The cells proliferated in the two types of porous scaffolds during the 4-week culture, with a greater 
proliferation rate in collagen scaffolds than that in collagen/HA scaffolds. The DNA amount in collagen 
scaffolds was significantly higher than that in collagen/HA scaffolds after 2-week culture. Synthesis of 
sGAG by chondrocytes in the porous scaffolds were also measured (Fig. 3.7b). The chondrocytes cultured in 
collagen scaffolds synthesized significantly higher amount of sGAG than those in collagen/HA scaffolds. 
The compressive modulus of cell/scaffold constructs was measured after cell culture for different time (Fig. 
3.7c). The compressive modulus of cell/scaffold constructs increased with culture time. Cell/scaffold 
constructs from collagen scaffolds had significantly higher compressive modulus than the constructs from 
collagen/HA scaffolds. 
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Fig. 3.7. The proliferation, synthesis of sGAG by chondrocytes and the mechanical property of cultured 
constructs. (a, b) The amount of DNA and sGAG in cell/scaffold constructs cultured for 1 week (1w), 2 
weeks (2w), 3 weeks or 4 weeks (4w). (c) The compressive modulus of cell/scaffolds constructs cultured for 
1 week, 2 weeks or 4 weeks. Means ± SD, N = 4. *, p < 0.05; **, p < 0.01; ***, p < 0.001. 
 
Chapter 3 
56 
 
 
Fig. 3.8. HE staining of cell/scaffolds constructs cultured for 4 weeks in vitro. Images were taken at low and 
high magnifications.  
 
Fig. 3.9. Safranin O staining of cell/scaffolds constructs cultured for 4 weeks in vitro. Images were taken at 
low and high magnifications.  
3.4.5 Synthesis of cartilage tissue 
The formation of cartilage tissue in cell/scaffold constructs were examined using HE staining and 
safranin O staining. HE staining of the cell/scaffold constructs cultured for 4 weeks showed that the 
chondrocytes cultured in collagen scaffolds synthesized ECM that filled the pores of collagen scaffolds (Fig. 
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3.8). In contrast, the chondrocytes cultured in collagen/HA scaffolds synthesized less ECM, most of which 
were synthesized in the peripheral region of porous scaffolds. Similarly, the safranin O staining of 
cell/scaffold constructs from collagen scaffolds showed more intense staining of sGAG compared with those 
from collagen/HA scaffolds (Fig. 3.9). These results showed that the chondrocytes cultured in collagen 
scaffolds synthesized more cartilage tissue than those cultured in collagen/HA scaffolds. 
Whether addition of high MW HA in hydrogel or porous scaffolds has a beneficial effect on 
chondrocytes is controversial. For example, when high MW HA was added in the culture medium to culture 
chondrocytes-seeded gelatin sponge, the DNA amount and sGAG synthesis increased with the concentration 
of HA [22]. When high MW HA was used to prepare collagen/HA scaffolds or hydrogel for chondrocyte 
culture, lower amount of HA (2%, 5%) promoted the synthesis of sGAG or mRNA of type II collagen and 
aggrecan but a greater amount of HA (10%, 14%)  inhibited the synthesis of sGAG and cartilage ECM [18, 
21]. It was found that increasing amount of HA in collagen/HA scaffolds led to reduction of pore size of 
porousscaffolds which could impede the migration, proliferation and function of chondrocytes [21]. For high 
concentrations of HA in hydrogels, HA molecules would overlap with each other forming entanglements and 
hydrophobic patches. These physical properties of HA were suggested to inhibit the synthesis of cartilage 
ECM [18]. However, other studies pointed out that HA affected chondrocyte behaviour through its chemical 
properties rather than its physical properties. For example, Toole et al. found that very low concentrations of 
HA in culture medium (as low as 1 ng/ml) inhibited chondrogenesis on chondrocytes [16]. Solursh et al. 
found that not only HA in culture medium inhibited chondrogenesis, the oligosaccharides derived from HA 
by using hyaluronidase caused more potent inhibition effect [25]. It is noteworthy that the uncontrolled pore 
structure of porous scaffolds and inhomogeneous distribution of HA in porous scaffolds or hydrogel could 
confound the effects of HA on the proliferation and ECM synthesis of chondrocytes.  
In the present study, homogeneous collagen/HA mixture suspension were prepared by suppression of 
PIC formation between collagen and HA. In addition, ice particulates were used as porogen to control the 
pore structure of collagen/HA scaffolds. The effects of high MW HA on chondrocytes were examined using 
the 3D collagen/HA scaffolds with well-controlled pore structure and homogeneous HA. We hypothesized 
that these collagen/HA scaffolds wound favour the chondrogenic behaviour of chondrocytes. However, the 
results showed that high MW HA in the porous scaffolds inhibited the cellular proliferation, synthesis of 
sGAG and formation of cartilage ECM from chondrocytes. Due to the inhibition of ECM formation within 
collagen/HA scaffolds, the mechanical property of cultured tissue from collagen/HA scaffolds were 
significantly lower than those from collagen scaffolds. It was also found that a lower amount of high MW 
HA (2%, 5%) in collagen/HA scaffolds prepared using ice particulates and suppression of PIC formation also 
caused inhibition effect on chondrocytes, with a trend of higher amount of HA causing greater inhibition (Fig. 
3.10). Our results were in agreement with previous studies that used high MW HA in the medium for 
two-dimensional culture of chondrocytes [25-28]. Different concentrations of high MW HA (from 1×10-4 
µg/ml to 100 µg/ml) was applied homogenously into culture medium, which inhibited the sGAG synthesis 
and accumulation of synthesized proteoglycan in the chondrocyte layer, with higher concentration of HA 
caused greater inhibition effect. By excluding the interfering factors such as uncontrolled pore structure and 
PIC formation in porous scaffolds, we also found that the homogenous HA in collagen/HA scaffolds 
inhibited the chondrogenesis in a similar dose-dependent manner. This inhibition effect from HA were found 
to be specific to chondrocytes but not to skin fibroblasts [26], which is in agreement of our previous study 
that showed collagen/HA scaffolds promoted the proliferation of skin fibroblasts [24]. 
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Fig. 3.10. The DNA amount (a) and sGAG amount (b) of cell/scaffold constructs from collagen/HA scaffolds that 
had different ratios of HA (0%, 2%, 5% or 10%). Bovine articular chondrocytes were cultured on these scaffolds 
for 2 weeks before the analysis. Means ± SD, N = 4. *, p < 0.05; **, p < 0.01. 
3.5 Conclusions 
Collagen/HA scaffolds with well-controlled pore structure and homogenous HA were prepared by using 
ice particulates as porogen and suppression of polyion complex formation. The homogeneous mixture 
suspension of collagen and HA were achieved by using NaCl to suppress the formation of polyion complex. 
The pore structure and mechanical property of collagen and collagen/HA scaffolds could be controlled by 
using ice particulates. Compared with collagen scaffolds, high MW HA in the porous collagen/HA scaffolds 
inhibited the proliferation, synthesis of sGAG and formation of cartilage ECM from chondrocytes. This 
study should provide additional information on the effects of high MW HA in porous scaffolds on the 
behaviour of chondrocytes in 3D culture. 
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Gelatin scaffolds with controlled pore structure and mechanical 
property for cartilage tissue engineering 
 
 
 
 
4.1 Summary 
Engineering of cartilage tissue in vitro using porous scaffolds and chondrocytes provides a promising 
approach for cartilage repair. However, nonuniform cell distribution and  heterogeneous tissue formation 
together with weak mechanical property of in vitro engineered cartilage limit their clinical application. In this 
study, gelatin porous scaffolds with homogeneous and open pores were prepared using ice particulates and 
freeze-drying. The scaffolds were used to culture bovine articular chondrocytes to engineer cartilage tissue in 
vitro. The pore structure and mechanical property of gelatin scaffolds could be well controlled by using 
different ratios of ice particulates to gelatin solution and different concentrations of gelatin. Gelatin scaffolds 
prepared from ≥70% ice particulates enabled homogeneous seeding of bovine articular chondrocytes 
throughout the scaffolds and formation of homogeneous cartilage ECM. While soft scaffolds underwent 
cellular contraction, stiff scaffolds resisted cellular contraction and had significantly higher cell proliferation 
and synthesis of sulfated glycosaminoglycan. Compared with the gelatin scaffolds prepared without ice 
particulates, the gelatin scaffolds prepared with ice particulates facilitated formation of homogeneous 
cartilage tissue with significantly higher compressive modulus. The gelatin scaffolds with highly open-pore 
structure and good mechanical property can be used to improve in vitro tissue-engineered cartilage.   
4.2 Introduction 
The self-repair of articular cartilage is difficult due to the avascular nature of cartilage tissue, low rate of 
chondrocyte proliferation and matrix turnover. Tissue engineering of articular cartilage in vitro is a promising 
approach for cartilage repair. Porous scaffolds are used to support cell adhesion and proliferation and to 
guide formation of cartilage tissue. The engineered tissue can be implanted to repair a cartilage defect. 
However, in vitro engineered cartilage often has thickness limitation,[1-4] heterogeneous cartilage 
extracellular matrix (ECM) and weak mechanical property which limit their clinical application.[5-8] One of 
the reasons of the problems is due to the scaffold structure. Heterogeneous structure and closed pores of 
scaffolds may hinder seeding and delivery of cells into the central parts of scaffolds, which leads to 
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formation of heterogeneous cartilage ECM, void cores accompanying with the poor mechanical property of 
engineered cartilage.[5, 9] In addition, cellular contraction of porous scaffolds is common during the 
engineering of cartilage tissue, which makes it hard to control the final size and shape of engineered 
tissue.[10-15] Therefore porous scaffolds with homogeneous, interconnected pores for homogeneous tissue 
formation and good mechanical property to withstand cellular contraction are necessary for successful 
engineering of cartilage in vitro.  
Polymer scaffolds prepared from direct freeze-drying of a polymer solution usually have few 
interconnected pores, which is more obvious when polymer concentration is increased to enhance the 
mechanical property of scaffolds.[16-18] By using ice particulate templates and freeze-drying, porous 
scaffolds with controlled open-pore structure and good mechanical property can be prepared.[19, 20] During 
the freeze-drying  process, the ice particulate templates act as porogen to form macropores, while the ice 
crystallization initiated by the templates can generate open-pore structure by forming micropores 
interconnecting those macropores.  
Gelatin is derived from collagen by hydrolysis and has the chemical composition similar to collagen but 
lack antigenicity and immunogenicity.[21-25] It has been used to engineer many kinds of tissues such as 
cartilage, bone and nerve tissues.[26-29] In this study, gelatin porous scaffolds were prepared using ice 
particulates and freeze-drying and were used to culture bovine articular chondrocytes to engineer cartilage 
tissue in vitro. The pore structure and mechanical property of gelatin scaffolds could be well controlled by 
using different ratios of ice particulates to gelatin solution and different concentrations of gelatin. Bovine 
articular chondrocytes could be homogeneously seeded and distributed throughout the gelatin scaffolds, 
which led to formation of homogeneous cartilage tissue.  Cellular contraction, proliferation, synthesis of 
cartilage ECM and the mechanical property of engineered tissue were analyzed to study the gelatin scaffolds 
with different properties for cartilage tissue engineering. The gelatin scaffolds with highly open pore 
structure and controlled mechanical property showed great promise to improve in vitro engineered cartilage. 
4.3 Materials and methods 
4.3.1 Preparation of porous gelatin scaffolds 
Gelatin porous scaffolds were prepared with ice particulates and freeze-drying (Fig. 4.1). 30 (v/v)% 
acetic acid was used as the solvent for gelatin to suppress the gelation of gelatin solutions at low temperature. 
2, 4, 6 and 8 (wt/v) % gelatin aqueous solutions were prepared by adding different amount of gelatin 
granules (porcine derived gelatin, Nitta Gelatin, Inc) into the 30 (v/v)% acetic acid and stirring at 45 ºC for 2 
hours and at room temperature for 4 hours. The gelatin solutions were stirred at -5 ºC for 20 minutes for 
temperature balance.  
The ice particulates were prepared by spraying pure water into liquid nitrogen. One sieve with 
mesh-hole size of 500 µm and another sieve with mesh-hole size of 425 µm were cooled and used to sieve 
the ice particulates in a low temperature chamber at -15 ºC. The obtained ice particulates with diameters in a 
range of 425-500 µm were transferred into a cooled glass bottle in the low temperature chamber and kept at 
-5 ºC for 2 hours for temperature balance before mixing with gelatin aqueous solution. The ice particulates 
were put into cooled gelatin aqueous solution and mixed at -5 ºC. To control the dimension of scaffolds, a 
silicone frame mold with an inner open dimension of 36.5 × 66.5 ×5.0 mm was placed on a copper plate 
wrapped with a perfluoroalkoxy (PFA) film (USL PFA film, Universal Co., Ltd) and was cooled at -5 ºC for 
2 hours. The gelatin solution/ice mixtures were poured into the cooled frame mold, firmly packed and 
Gelatin scaffolds with controlled pore structure and mechanical property 
63 
 
covered with a cooled glass plate wrapped with PFA film. The whole construct was transferred into a -80 ºC 
freezer and kept there for 12 hours. And then the frozen mixture was detached from the mold and 
freeze-dried at a vacuum of less than 5 Pa for 48 hours to obtain gelatin porous scaffolds. 
Two sets of gelatin scaffolds were prepared. One set of scaffolds was prepared from 4 (wt/v)% gelatin 
aqueous solution and the mixing ratio of the volume of gelatin solution to the weight of ice particulates at 
20/80, 25/75, 30/70, 40/60 and 50/50 (ml/g), which were designated as G20, G25, G30, G40 and G50 
scaffolds, respectively. The other set was prepared from 2, 4, 6 and 8 (wt/v)% gelatin solutions and a fixed 
mixing ratio of the volume of gelatin solution to the weight of ice particulates at 30/70, which were 
designated as 2%G, 4%G, 6%G and 8%G scaffolds, respectively. Control samples were prepared from 4 
(wt/v)% gelatin solution without using ice particulates. 
 
 
 
Fig. 4.1. Preparation of open-porous gelatin scaffolds by using ice particulates and freeze-drying. 
4.3.2 Crosslinking of gelatin scaffold 
Three solvents of decreasing ethanol concentrations (ethanol/water = 95/5, 90/10, or 85/15, v/v) were 
used to prepare crosslinking solutions that contained 50 mM 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC, Peptide Institute, Inc.), 20 mM N-hydroxysuccinimide (NHS, Wako Pure Chemical 
Industries, Ltd.) and 0.1 (wt/v)%  2-(N-morpholino) ethanesulfonic acid (MES).[18] Gelatin scaffolds were 
crosslinked sequentially in the three crosslinking solutions of decreasing ethanol fraction (from 95/5 to 90/10 
to 85/15). Each scaffold was kept in the first crosslinking solution (ethanol/water, 95/5, 30 ml) for 8 hours, 
followed by the second solution (ethanol/water, 90/10, 30 ml) for 8 hours and the third solution 
(ethanol/water, 85/15, 30 ml) for another 8 hours. The crosslinked scaffolds were rinsed with MilliQ water 
for 10 times at room temperature and freeze-dried again at a vacuum of less than 5 Pa for 48 hours to obtain 
the final scaffolds. 
 
4.3.3 Scanning electron microscopy and compressive test 
Crosslinked gelatin scaffolds were cut with a blade and their cross sections were sputter-coated with 
platinum. The cross sections were observed at 10 kV with a scanning electron microscope (JSM-5610, JEOL, 
Ltd.). Pore size was analyzed by measuring the diameters of pores (≥40 pores per image) on four SEM 
images of each type of scaffolds with the ImageJ software(ImageJ2, NIH). For compressive test, the 
crosslinked gelatin scaffolds were cut into disks (diameter = 6 mm) with a biopsy punch and the disks were 
cut into 3-mm-thick using two blades spaced 3 mm apart. Some samples were hydrated by degassing the 
scaffold disks in phosphate buffered saline (PBS) and soaking in PBS for 2 hours. Scaffold disks in dry and 
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hydrated states were used for the compressive test. The scaffold disks were compressed at a rate of 0.1 mm/s 
to generate stress-strain curves with a texture analyzer (TA.XTPlus, Texture Technologies Corp.). To study 
the mechanical isotropy of gelatin scaffolds, the control scaffolds and G30 were cut into cubes (5 × 5 × 5 
mm) and compressed in three directions (X, Y and Z axis of samples) using the same machine setting as the 
above. The Young’s modulus was calculated from the initial linear region of the stress-strain curve and 
sample dimension. Four samples of each type of scaffold were used to calculate the average and standard 
deviation. 
4.3.4 Culture of chondrocytes in scaffolds 
Bovine articular chondrocytes were isolated from articular cartilage of the knees of a 9-week old female 
calf from a local slaughterhouse. Cartilage tissue was minced into 1-2 mm pieces and digested using a 
0.2% w/v collagenase type II (Worthington Biochemical, Lakewood, NJ) solution overnight at 37°C under 
shaking. Isolated chondrocytes were collected and cultured with culture medium in 175-cm2 tissue culture 
flasks. The culture medium was prepared from high-glucose Dulbecco’s Modified Eagle’s Medium (D6546, 
Sigma-Aldrich Co.) supplemented with 10% fetal bovine serum, 4 mM glutamine, 100 U/ml penicillin, 
100 μg/ml streptomycin, 0.1 mM nonessential amino acids, 0.4 mM proline, 1 mM sodium pyruvate and 
50 μg/ml ascorbic acid. Culture medium was refreshed every 3 days. The chondrocytes reaching confluence 
were treated with a trypsin/EDTA solution, harvested and re-plated in 175-cm2 tissue culture flasks. The 
chondrocytes reaching confluence were harvested (P2 chondrocytes) and suspended in culture medium to get 
a cell suspension of 6.67 × 107 cells/ml for cell seeding.  
Porous gelatin scaffolds were punched into disks (6 mm in diameter and 3 mm in thickness) as above 
described, sterilized with 70(v/v)% ethanol aqueous solution, washed with PBS for 6 times and conditioned 
with culture medium at 37 °C for 2 hours. After absorbing away the culture medium from the scaffold disks 
using sterilized Kimwipe, 60 µl of the chondrocyte suspension was pipetted onto the scaffold and incubated 
at 37°C. After 3 hours of incubation, the scaffolds were turned up-side down and the medium inside was 
absorbed away. Another 60 µl chondrocyte suspension was pipetted onto the scaffold disks and incubated at 
37°C for 3 hours. Seeded scaffolds were transferred to new 6-well plates and culture medium was added. The 
leaked cells in 6-well plates were tripsinized and counted to calculate the efficiency of seeding cells in 
gelatin scaffolds (seeding efficiency = (1-number of unseeded cells / total number of cells for seeding) × 
100%). Four sampes per group were counted for the calculation. After 1 day culture, all the cell/scaffold 
constructs were transferred to 25-cm2 tissue culture flasks and cultured in the medium under shaking (60 
rpm) for 8 weeks. 
4.3.5 Cell distribution in seeded scaffolds 
Cell/scaffold constructs cultured for 1 day were washed with PBS and fixed in 10% neutral buffered 
formalin for 2 days. The constructs were dehydrated, embedded in paraffin and sectioned to get the vertical 
cross sections of constructs (8 μm thick). Cell nuclei in the sections were stained with 2 μg/ml 
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI, Dojindo Molecular Technologies, Inc.) and observed 
under a fluorescence microscope (Olympus, Tokyo, Japan). The images of nuclei staining were imported into 
ImageJ software to analyze the integrated fluorescence intensities of three regions of interest (ROI: 500 × 
1000 µm rectangle), the upper zone, the center and the lower zone of cross section.[30] The integrated 
intensity of each ROI was divided by the area of ROI to obtain the average intensity. The average intensity of 
each ROI was subtracted from the average intensity of background (Fig. S1). Four images of each kind of 
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scaffold were used for the analysis. 
4.3.6 Biochemical quantification and compressive test of engineered constructs 
Proliferation of the chondrocytes in scaffolds was evaluated by quantifying the DNA amount as 
described previously.[18] Briefly, cell/scaffold constructs cultured for 8 weeks were harvested, freeze-dried 
and digested with papain solution. An aliquot of the papain digests was used to measure the DNA content 
with Hoechst 33258 dye (Sigma-Aldrich) and an FP-6500 spectrofluorometer (JASCO, Tokyo, Japan). 
Sulfated glycosaminoglycan (sGAG) content was analyzed using Blyscan™ Glycosaminoglycan Assay 
(Biocolor Ltd., UK) from the above papain digests according to the manufacturer’s instructions. The 
compressive modulus of cell/scaffold constructs after 8 weeks culture was determined by using the 
compressive test described above. Four samples were used to calculate the average and standard deviation. 
4.3.7 Histological and immunological staining 
Cell/scaffold constructs cultured for 8 weeks were washed with PBS and fixed in 10% neutral buffered 
formalin for 2 days at room temperature. The constructs were dehydrated, embedded in paraffin and 
sectioned to get the vertical cross sections of constructs (8 μm thick). The cross sections were deparaffinized 
and stained with Safranin O and light green staining. The cross sections were also immunologically stained 
for type II collagen. Briefly, the deparaffinized sections were incubated with proteinase K for 10 minutes for 
antigen retrieval and incubated with peroxidase blocking solution for 5 minutes and 10% goat serum solution 
for 30 minutes. And then the sections were incubated with rabbit polyclonal anti-collagen type II (in a 1:100 
working dilution) (Thermo Scientific, Rockford, IL)  for 1 hour, followed by incubation with the 
peroxidase-labeled polymer-conjugated second antibody (EnVision+ System-HRP (DAB), Dako, CA) for 
30 minutes. The sections were then incubated with 3,3’-diaminobenzidine (DAB) for 5 minutes to develop 
color. All procedures were performed at room temperature. Stained tissue sections were observed under a 
light microscope. 
4.3.8 Real-time PCR 
The expression of genes for cartilage ECM by chondrocytes in the cell/scaffold constructs (n = 3) was 
analyzed using real-time polymerase chain reaction (real-time PCR). After culture for 8 weeks, each 
cell/scaffold construct was rinsed with PBS buffer, immersed in 1 ml Sepasol-RNA I Super G solution 
(Nacalai Tesque, Inc.) and frozen at -80 °C. The frozen constructs were crushed into powder by an electric 
crusher and transferred back into the Sepasol solution to isolate the RNA from the cells. The RNA was 
converted to cDNA by MuLV reverse transcriptase (Applied Biosystems, USA). Real-time PCR was used to 
amplify hypoxanthine guanine phosphoribosyl transferase 1 (Hprt1), glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh), type I collagen (Col1a2), type II collagen (Col2a1) and aggrecan (Acan). The 
reactions were performed with 0.2 μl cDNA, 18 mM forward / reverse primers, 5 mM PCR probe and qPCR 
Master Mix (Eurogentec, Seraing, Belgium) in duplicate. The reactions were run for 40 cycles using a 7500 
Real-Time PCR System (Applied Belgium). The expression levels of Hprt1 were used as endogenous 
controls and the gene expression levels relative to Gapdh were calculated using a comparative Ct 
method.[31] The primer and probe sequences were as follows: Hprt1: forward primer 
5′-TGGCGTCCCAGTGAAATCA-3′, reverse primer, 5′-AGCAGCTGGCCACAGAACA-3′, probe, 
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5′-CAGTGACATGATCCAATG-3′; Gapdh, forward primer, 5′-GCATCGTGGAGGGACTTATGA -3′, 
reverse primer, 5′-GGGCCATCCACAGTCTTCTG-3′, probe, 5′-CACTGTCCACGCC ATCACTGCCA-3′; 
Col1a2, forward primer, 5′-TGGCAAAGACGGTCG CAT-3′, reverse primer, 
5′-CCTTGGGTCTGAGAGAAGTTGGT-3′, probe, 5′-GTAACCACCAC CACTTG-3′;[32] Col2a1, forward 
primer, 5′-AAGAAACACATCTGGTTTGGAGAAA-3′, reverse primer, 
5′-TGGGAGCCAGGTTGTCATC-3′, probe, 5′-CAACGGTGGCTTCCACTTCAGCTATG G-3′ [32]; Acan, 
forward primer, 5′-CCAACGAAACCTATGACGTGTACT-3′, reverse primer, 
5′-GCACTCGTTGGCTGCCTC-3′, probe, 5′-ATGTTGCATAGAAGACCTCGCCCTCCAT-3′ [32]. 
4.3.9 Statistical analysis 
One-way analysis of variance (ANOVA) was used to evaluate the experimental values of the groups of 
scaffolds prepared using different fractions of ice particulates or of the groups of scaffolds prepared using 
different concentrations of gelatin. Student-t test was used to compare two groups of data. Statistical 
differences were considered significant if p<0.05. 
4.4 Results 
4.4.1 Pore structure of gelatin scaffolds  
Porous gelatin scaffolds prepared using different ratios of ice particulates (G20, G25, G30, G40 and 
G50) and different concentrations of gelatin aqueous solution (2%G, 4%G, 6%G and 8%G) are shown in Fig. 
4.2a. The scaffolds prepared with ice particulates had round macropores that mirrored the ice particulates 
used as porogen. The scaffolds prepared with ≥70% ice particulates (G20, G25, G30, 2%G, 4%G, 6%G and 
8%G) had open-pore structure with the macropores interconnected by micropores on their walls. Compared 
with these scaffolds, the scaffolds prepared with low ratio of ice particulates (G40 and G50) had sparse, less 
interconnected macropores and thick walls. Analysis of scaffold pore size (Table 4.1) showed that the size of 
macropores of these scaffolds was all similar to that of ice particulates while the size of micropores 
decreased with the decrease of ice particulate ratio (G20>G25>G30>G40>G50) and the increase of gelatin 
concentration (2%G>4%G>6%G>8%G). The control group, however, had heterogeneous structure with 
lamellar walls of different directions and the pores were less interconnected due these closed lamellar walls.  
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Fig. 4.2. Pore structure and mechanical property of crosslinked gelatin scaffolds. a, SEM images of the cross 
sections of gelatin porous scaffolds. G20, G25, G30, G40 and G50 represent scaffolds which were prepared 
with 4 (wt/v)% gelatin aqueous solution and the mixing ratio of the volume of gelatin solution to the weight 
of ice particulates at 20/80, 25/75, 30/70, 40/60 and 50/50, respectively. 2%G, 4%G, 6%G and 8%G 
represent scaffolds which were prepared with a fixed mixing ratio at 30/70 and gelatin concentration of 2, 4, 
6 and 8 (wt/v)%, respectively. The control group was prepared with 4 (wt/v)% gelatin aqueous solution 
without ice particulates. Scale bar = 100 µm. Compressive modulus of dry (b) or hydrated (c) gelatin 
scaffolds. High ratio of gelatin solution or high concentration of gelatin could significantly increase the 
compressive modulus of the scaffolds (**, p<0.001 by ANOVA). Data represent mean ± SD (n=4).   
 
 
Table 4.1. Pore size (macropores and micropores) of the gelatin scaffolds. Data represent mean ±SD. 
Samples G20 G25 G30 G40 G50 
Macropores (µm) 462±65 478±49 453±75 464±68 460±63 
Micropores (µm) 155±66 120±48 102±34 60±45 47±28 
Samples Control 2%G 4%G 6%G 8%G 
Macropores (µm) 334±256 484±65 453±75 463±43 475±56 
Micropores (µm) - 173±87 102±34 62±36 58±46 
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4.4.2 Mechanical property of gelatin scaffolds 
The compressive modulus of gelatin scaffolds were measured in both dry state and wet state (Fig. 4.2b, 
c). The compressive modulus of gelatin scaffolds increased with the ratio of gelatin solution and the 
concentration of gelatin used in scaffold preparation, both in the dry state and the wet state. Using high ratio 
of gelatin solution and high concentration of gelatin could significantly increase the compressive modulus of 
gelatin scaffolds (ANOVA, p<0.001). The compressive modulus of control gelatin scaffold measured in 
different directions of compression showed a great variation (Table 4.2). However, a typical gelatin scaffold 
prepared using ice particulates (G30) had similar compressive modulus measured in different directions of 
compression.  
 
Table 4.2. Compressive modulus (kPa) of control scaffolds and G30 scaffolds measured using different 
directions of compression (X, Y or Z). Data represent mean ± SD (n=4).   
Direction of compression X-axis Y-axis Z-axis 
Control 76.2±22.4 87.9±24.0 27.0±8.4 
G30 89.8±3.8 87.6±3.6 92.0±8.1 
 
4.4.3 Cell distribution in scaffolds 
To visualize the distribution of chondrocytes in scaffolds, bovine chondrocytes were seeded into gelatin 
scaffolds and the cell/scaffold constructs after 1-day culture were fixed, sectioned and stained with DAPI 
(Fig. 4.3). For scaffolds prepared using ≥70% ice particulates (G20, G25, G30, 2%G, 4%G, 6%G and 8%G), 
chondrocytes could be seeded homogeneously throughout the whole scaffold. For scaffolds prepared using 
less ice particulates (G40 and G50), chondrocytes merely penetrated into the peripheral region of the 
scaffolds, leaving a central core with less cells. For the control scaffolds, chondrocytes were densely 
deposited on the surface of the scaffolds and few chondrocytes penetrated into the inner region. The gelatin 
scaffolds prepared with ice particulates had high seeding efficiency due to their interconnected pore 
structures compared to the control scaffolds (Table 4.3). 
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Fig. 4.3. Cell distribution in the getatin scaffolds after 1-day culture. Cell nuclei were stained by DAPI. The 
inserted images are the whole cross sections of scaffolds. Scale bars: 200 µm for high-magnification images; 
1 mm for inserted images. The intensity of nuclei staining in three regions of interest (the upper, center and 
the lower zone of cross section) were analyzed. 
 
Table 4.3. The efficiency of seeding chondrocytes (seeding efficiency) in gelatin scaffolds.  Data represent 
mean ±SD. 
Samples G20 G25 G30 G40 G50 
Seeding efficiency (%) 94.5±4.9 95.9±3.0 96.6±3.1 97.0±3.0 98.3±1.2 
Samples Control 2%G 4%G 6%G 8%G 
Seeding efficiency (%) 68.3±5.2 93.8±4.7 96.6±3.1 97.8±2.1 98.5±1.2 
 
4.4.4 Cellular contraction of scaffolds 
Gelatin scaffolds underwent cellular contraction during the 8-week in vitro culture. After 8 weeks, all 
the cell/scaffold constructs except the control group remained the round-disk shape (Fig. 4.4a). The 
mechanical strength of these scaffolds affected the final diameter of the cell/scaffold constructs (Fig.4.4b). 
Soft scaffolds prepared using high fraction of ice particulates (G20) or low concentration of gelatin (2%G) 
exhibited the most contraction. Stiff scaffolds such as G50 and 6%G had much less contraction and the 8%G 
scaffolds kept their original size. The control samples contracted into irregular-shaped blocks although their 
diameters remained larger than the soft scaffolds prepared using ice particulates. 
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Fig. 4.4. Gross appearance (a) and diameter (b) of the cell/scaffold constructs after 8-week culture. The 
diameter was normalized to the initial diameter of scaffold disks. Data represent mean ± SD (n=4). 
Quantification of DNA amount (c) and sGAG amount (d) in the cell/scaffold constructs after 8-week culture. 
Compressive modulus of the cell/scaffold constructs after 8-week culture (e). The inserted narrow columns 
represent the compressive modulus of hydrated scaffolds before cell culture. *, p<0.05 compared with G20, 
G25, G30 and Control; #, p<0.05 compared with 2%G and 4%G; $, p<0.05 compared with all other groups. 
Data represent mean ± SD (n=4).   
 
4.4.5 DNA, sGAG quantification and mechanical property of engineered tissue 
After 8-week culture, the DNA content in stiff scaffolds was significantly higher than that in soft 
scaffolds and the 8%G group had 3.1 fold higher DNA content than the 2%G group (Fig. 4.4c).  The 
synthesis of sGAG by chondrocytes in scaffolds showed the similar pattern as that of DNA content. More 
sGAG was produced in stiff scaffolds (Fig. 4.4d). Compressive modulus of cartilage tissue engineered from 
8% scaffolds and G50 scaffolds had higher values compared with those from other scaffold groups. After cell 
culture all the scaffolds prepared with ice particulates showed significantly higher compressive modulus than 
the control gelatin scaffolds (p<0.05) (Fig. 4.4e).  
 
4.4.6 Histological stainig of cartilage tissue 
The formation of cartilage ECM (sGAG and type II collagen) was examined using Safranin O staining 
and type II collagen immunostaining (Fig. 4.5). Cartilage tissue engineered from scaffolds prepared using 
≥70% ice particulates (G20, G25, G30, 2%G, 4%G, 6%G and 8%G) had homogeneous staining of sGAG and 
type II collagen. Cartilage tissue engineered from scaffolds prepared with less ratio of ice particulates (G40 
and G50) had intense staining of sGAG and type II collagen at the periphery region of scaffolds. For the 
control scaffold prepared without ice particulates, however, synthesis of cartilage ECM was mainly observed 
on the surface of scaffolds.  
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Fig. 4.5. Safranin O staining (a) and immunostaining of type II collagen (b) of the cell/scaffold constructs 
after 8-week culture. Scale bar = 500 µm.  
4.4.7 Gene expression of cell/scaffold constructs 
Cell/scaffold constructs cultured for 8 weeks were harvested for analysis of gene expression (Fig. 4.6). 
The expression levels of type I collagen in all scaffolds were similar except that in the G50 and control 
groups which was significantly higher compared with other groups. Chondrocytes in the G20, G25 and 2%G 
scaffolds had higher expression levels of type II collagen compared to those in other scaffold groups. The 
expression level of aggrecan by chondrocytes in all scaffold groups did not show a significant difference. 
      
Fig. 4.6. Expression level of genes encoding type I collagen (a), type II collagen (b) and aggrecan (c) in 
cell/scaffold constructs after 8-week culture.  *, p<0.05 compared with G20, G25, G30 and G40; #, p<0.05 
compared with G30, G40, G50 and Control; $, p<0.05 compared with 4%G, 6%G and 8%G. Data represent 
mean ± SD (n=3).   
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4.5 Discussion 
Gelatin scaffolds with open-pore structure and good mechanical property could be prepared by using ice 
particulates as a porogen material. Gelatin solutions were cooled at low temperature, mixed with ice 
particulates and freeze-dried. Freeze-drying of the gelatin solution/ice particulates mixture resulted in 
formation of open porous gelatin scaffolds having macropores which mirrored the ice particulate templates 
and micropores which mirrored the ice crystals formed during freezing process. The ratio of ice particulates 
higher than 70% enabled formation of well-interconnected macropores. The mechanical property of gelatin 
scaffolds could be improved by using high ratio of gelatin solution and high concentration of gelatin, as high 
amount of gelatin could form dense matrix surrounding the macropores to strengthen the scaffolds.[17, 33] 
Without using ice particulates, control scaffolds had heterogeneous porous structure and different 
compressive modulus in different directions of compressiom, showing the heterogeneity of mechanical 
property. 
The open-pore structure of gelatin scaffolds prepared by using high ratio of ice particulates (≥70%) 
facilitated even cell seeding and formation of homogeneous cartilage ECM throughout the scaffolds. The 
pores of these scaffolds were well interconnected, which allowed penetration of chondrocytes into the full 
thickness of scaffolds after cell seeding and synthesis of homogeneous cartilage tissue during cell culture. 
Scaffolds prepared by using low ratio of ice particulates (G40 and G50) had less interconnected pore 
structure and therefore cells were predominantly distributed at the peripheral region of the scaffolds to form 
dense ECM layers at the peripehral region. Chondrocytes seeded in control scaffolds mainly adhered and 
synthesized ECM on scaffold surface due to the heterogeneous and less interconnected pore structure.  
Chondrocytes in stiff scaffolds (G40, G50, 6%G and 8%G) had a significantly greater rate of 
proliferation compared with those in soft scaffolds. While soft scaffolds contracted significantly during cell 
culture which might limit cell proliferation,[34] stiff scaffolds could resist cellular contraction, retain their 
pore structure and keep pore space that could facilitate cell proliferation. It has been reported that 
chondrocytes react to their substrate of different stiffness and change their behaviors such as cell spreading 
and mitosis.[34-36] Focal adhesions of cells link the ECM with the intracellular cytoskeleton, which can 
transduce the force between the ECM and cytoskeleton into biochemical signals to affect cell behaviors. Stiff 
ECM microenvironment has been reported to  activate the focal adhesion kinase, which can activate 
pathways to promote cell proliferation.[37, 38] Therefore the stiffness of gelatin scaffolds might have 
affected the cell proliferation through mechano-transductive pathways. Other factors such as the permeability 
of different scaffolds might also affect cell proliferation through different diffusivity of nutrients in different 
cell/scaffold constructs. However, these parameters were not quantified because they could change with 
cellular contraction and accumulation of ECM in scaffolds during cell culture. In addition, the aggrecan 
expression level of chondrocytes cultured in different scaffolds were similar (Fig.6c). Therefore, the stiff 
scaffolds which had greater number of cells should have higher production of sGAG. 
Chondrocytes cultured in G50 and control scaffolds had higher expression of type I collagen. G40 and 
G50 were prepared from smaller ratios of ice particulates, which caused some non-interconnected pores in 
the scaffolds. Less cell infiltration in G40 and G50 scaffolds caused that some cells grew on the surface of 
scaffolds. Cells growing on the surface were similar to the 2D culture condition, which was unsuitable to 
maintain the chondrogenic phenotype of chondrocytes.[39] This might explain the higher expression of type 
I collagen by chondrocytes cultured in G50 and control scaffolds on which many cells grew on the scaffold 
surface. 
Improved mechanical property and open-pore structure of scaffolds inhibited cellular contraction, 
enabled greater cell proliferation and formation of homnogeneous cartilage tissue which in turn improved the 
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mechanical property of engineered tissue. Inhibition of cellular contraction of scaffolds makes it possible to 
control the final size and shape of engineered cartilage tissue. The control scaffolds contracted into 
irregular-shaped blocks due to their low mechanical property and heterogeneous pore structure. Cell/scaffold 
constructs from control scaffolds also had much lower compressive modulus compared to other groups, due 
to the formation of cartilage ECM only on the scaffold surface. While the in vitro engineered cartilage tissue 
had mechanical properties lower than the natural cartilage tissue, it is expected that after implantation the 
more favorable in vivo environment could turn the in vitro engineered tissue into mature cartilage tissue and 
further improve their mechanical property.[40, 41]  
4.6 Conclusions 
In summary, gelatin scaffolds with open-pore structure and good mechanical property could be prepared 
by using ice particulates and freeze drying. The size and structure of pores and mechanical property of 
gelatin scaffolds could be well controlled by using different ratios of ice particulates to gelatin solution and 
different concentrations of gelatin. Gelatin scaffolds prepared from ≥70% ice particulates enabled 
homogeneous seeding of bovine articular chondrocytes throughout the scaffolds and formation of 
homogeneous cartilage ECM. While soft scaffolds underwent cellular contraction, stiff scaffolds resisted 
contraction and had significantly higher cell proliferation and synthesis of sulfated glycosaminoglycan. 
Compared with the gelatin scaffolds prepared without ice particulates, the gelatin scaffolds prepared with ice 
particulates facilitated formation of homogeneous cartilage tissue with significantly higher compressive 
modulus. The gelatin scaffolds with highly open-pore structure and good mechanical property can be used to 
improve in vitro tissue-engineered cartilage.  
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Chapter 5 
 
 
Preparation of 3D microgrooved collagen scaffolds for multi-layered 
skeletal muscle tissue engineering 
 
 
 
5.1 Summary 
Preparation of three-dimensional (3D) micropatterned porous scaffolds remains a great challenge for 
engineering of highly organized tissues such as skeletal muscle tissue and cardiac tissue. Two-dimensional 
(2D) micropatterned surfaces with periodic features (several nanometers to less than 100 µm) are commonly 
used to guide the alignment of muscle myoblasts and myotubes and lead to formation of pre-patterned cell 
sheets. However, cell sheets from 2D patterned surfaces have limited thickness, and harvesting the cell 
sheets for implantation is inconvenient and can lead to less alignment of myotubes. 3D micropatterned 
scaffolds can promote cell alignment and muscle tissue formation. In this study, we developed a novel type 
of 3D porous collagen scaffolds with concave microgrooves that mimic muscle basement membrane to 
engineer skeletal muscle tissue. Highly aligned and multi-layered muscle bundle tissues were engineered by 
controlling the size of microgrooves and cell seeding concentration. Myoblasts in the engineered muscle 
tissue were well-aligned and had high expression of myosin heavy chain and synthesis of muscle 
extracellular matrix. The microgrooved collagen scaffolds could be used to engineer organized multi-layered 
muscle tissue for implantation to repair/restore the function of diseased tissues or be used to investigate the 
cell-cell interaction in 3D microscale topography.  
 
5.2 Introduction  
Skeletal muscle tissue malfunction or loss can be caused by inflammatory muscle diseases, aging of 
muscle and sports injuries [1-3]. In skeletal muscle tissue, muscle fibers which are surrounded by basement 
membrane are highly aligned and assembled into organized muscle bundles to achieve muscle functions [4, 
5]. To engineer such well-organized tissue for tissue/organ repair, two-dimensional (2D) micropatterned 
surfaces with periodic features (several nanometer to less than 100 µm) have been fabricated by various 
methods, such as aligned nanofiber by electrospinning [6-8], groove/ridge micro- and nanopatterns by 
photolithography or spin coating [9-13], aligned extracellular matrix (ECM) molecules or cell-adhesive 
polymer by contact printing [14, 15]. The 2D micropatterned surfaces can guide alignment of muscle 
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myoblasts and myotubes from fusion of myoblasts and lead to formation of pre-patterned cell sheets [16-19]. 
However, cell sheets from 2D patterned surfaces have limited thickness, and harvesting the cell sheets for 
implantation is inconvenient and can lead to less alignment of myotubes. Three-dimensional (3D) 
micropatterned scaffolds that guide cell alignment and tissue formation are desirable to engineer the 
organized skeletal muscle tissue.   
3D micropatterned porous collagen scaffolds with well controlled pore structures can be prepared via 
liquid dispensing and freeze-drying [20]. In this study, we used the water dispensing and freeze-drying to 
prepare 3D microgrooved collagen scaffolds for skeletal muscle tissue engineering (SMTE). With this 
method, we could use extracellular matrix (ECM) components such as collagen to prepare 3D 
micropatterned scaffolds for tissue engineering and the concave structure of microgrooves to mimic the 
tubular structure of muscle basement membrane which surrounds each muscle fiber. Muscle basement 
membrane is mainly composed of ECM molecules such as collagen and laminin and has a tubular shape, 
which promotes muscle development and myogenesis and maintains muscle integrity [21-23]. While many 
studies have used scaffolds of synthetic polymer and sharp-edged micropatterns for SMTE [24-30], we tried 
to use the 3D collagen scaffolds with large concave microgrooves (120-380 µm) to mimic the ECM 
environment and topographical characteristic of muscle fibers. Another advantage of the 3D micropatterned 
scaffolds over 2D micropatterned surfaces is that the engineered organized muscle tissue in 3D scaffolds can 
be directly implanted for tissue repair. By culturing rat L6 skeletal myoblasts in the 3D microgrooved 
collagen scaffolds we developed multi-layered muscle bundle tissue in which myoblasts aligned and formed 
myotubes. The formation of aligned muscle bundles from L6 myoblasts was dependent on the size of 
microgrooves and cell seeding concentration. The 3D structural micropatterns have potential to repair 
organized tissues or organs which is hard to achieve via traditional methods or be used to investigate cell-cell 
interaction in 3D microscale topography [26, 31-33]. 
5.3 Materials and methods  
5.3.1 Scaffold preparation  
Perfluoroalkoxy film (PFA film, Universal Co., Ltd) was wrapped on a copper plate which was cooled 
by liquid nitrogen. Dispensing nozzle of a jet dispenser (MJET-3-CTR, Musashi Engineering Inc.) which 
was controlled by a SHOT mini 200α (Musashi Engineering Inc.) moved back and forth over the PFA 
film-wrapped copper plate and ejected water droplets that sequentially fell onto the cooled plate. The water 
droplets were immediately frozen and formed continuous frozen ice lines (Fig. 5.1a,b). CAD programs were 
used to control the movement of dispensing nozzle which enabled formation of aligned frozen ice lines on 
the plate. The width of frozen ice lines was controlled by the pressure (0.001MPa) that pumped water out of 
the nozzle and different types of nozzles (32-35G). The temperature of the copper plate bearing frozen ice 
lines was balanced to -5 °C, and the plate was covered with a silicon frame (thickness: 500 μm). Cooled type 
I collagen aqueous solution (1 (wt/v)% in a mixture of ethanol and pure water (10:90 v/v, pH 3.0), -5 °C) 
(Nitta Gelatin Inc.) was cast onto the frozen ice lines and covered with a glass plate. The whole construct 
was frozen in liquid nitrogen and freeze-dried to get a 3D microgrooved scaffold. Different scaffolds (G120, 
G200 and G380) were prepared by using frozen lines of different widths. Scaffolds with a flat surface as a 
control group were prepared without using ice lines. All scaffolds were cross-linked using a solution of 50 
mM 1-ethyl-3-(3-dimethyllaminopropyl)carbodiimide and 20 mM N-hydroxysuccinimide at room 
temperature for 12 h [34], rinsed with pure water and freeze-dried.  
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5.3.2 Scanning electron microscopy and porosity measurement 
Scaffold samples were cut using sharp blades, fixated using carbon tape, sputter-coated with platinum 
and observed with a scanning electron microscope (SEM) at the acceleration voltage of  10 kV (JSM-5610, 
JEOL, Ltd.). The SEM images were imported in ImageJ software to analyze the widths and depths of 
scaffolds. 4 images of each type of samples were analyzed and at least 6 microgrooves in each image were 
analyzed. The porosity of different kinds of scaffolds was measured using the method as reported previously 
[35].  
5.3.3 Cell culture in scaffolds 
Rat L6 skeletal muscle myoblasts (American Type Culture Collection) were subcultured in Dulbecco's 
Modified Eagle's Medium (D8437, Sigma-Aldrich) supplemented with 10% fetal bovine serum and 10% 
horse serum and 1% penicillin / streptomycin. Microgrooved scaffolds were punched into disks (diameter: 10 
mm), sterilized in 70% ethanol, rinsed in phosphate buffered saline (PBS) and covered with a glass ring 
(inner diameter : 10 mm) in 12-well plates. After culture medium (2 ml) was added beside each glass ring, 
myoblasts in cell suspension (200 µl) were seeded at 3 different concentrations on the microgrooved collagen 
scaffolds inside the glass rings. The cells were cultured for 2 days followed by removal of glass rings. And 
then the samples were cultured in fusion medium (FM) (D8437 + 2% horse serum + 1% penicillin / 
streptomycin) for another 5 or 12 days. For SEM observation, cell-seeded samples were fixed with 2.5% 
glutaraldehyde in PBS for 2 hours, rinsed in pure water, freeze-dried and observed as mentioned above. 
5.3.4 Staining of engineered tissue  
After 7 or 14 days of culture, cell-scaffold samples were fixed using 4% paraformaldehyde (30 min, 
room temperature(RT)), rinsed in PBS, and incubated in 0.2% Triton X-100 (10 min, RT). For staining of 
F-actin, Alexa Fluor 488 Phalloidin (Life Technologies) was diluted in PBS (1:40) and incubated with the 
samples for 40 min. For staining of myosin heavy chain (MHC), the samples were blocked in 1% BSA for 20 
min, incubated in 1% BSA-diluted MF20 (Developmental Studies Hybridoma Bank) (1:300) overnight at 4 
ºC, followed by rinsing in PBS and incubation in 1% BSA-diluted Goat anti-Mouse IgG Secondary Antibody 
(Life Technologies) (1:500) for 1 h at RT. For double staining of F-actin and MHC, the samples were 
incubated in diluted MF20 and Goat anti-Mouse IgG Secondary Antibody followed by incubation in Alexa 
Fluor® 594 Phalloidin (Life Technologies) at the same conditions described above. Finally cell nuclei were 
stained using PBS-diluted Cellstain-DAPI Solution (Dojindo)(1:500, 10 min, RT). Samples were rinsed in 
PBS and imaged using a fluorescence microscope (Olympus) or a confocal microscope (Zeiss LSM 510 
Meta).  
For Hematoxylin and Eosin (HE) staining and laminin immunostaining, cell-scaffold samples were 
fixated in 10% neutral buffered saline, dehydrated in ethanol series and embedded in paraffin. 8 µm-thick 
tissue sections were sectioned from the paraffin-embedded samples and used for HE staining and laminin 
immunostaining (Laminin α-4 (H-194), Santa Cruz Biotechnology, Inc.).  
5.3.5 Analysis of cell alignment  
To check cell nuclei alignment within cell bundles, confocal images of DAPI-stained nuclei were 
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imported in ImageJ software to analyze the angles between the major axis of nuclei and the central axis of 
cell bundle [36]. 4 images of each type of samples were analyzed and at least 60 nuclei in each image were 
analyzed.   
5.3.6 Real-time PCR 
Total RNA of cell-scaffold constructs after 7 or 14 d of culture was extracted by using RNeasy Plus mini 
kit (Qiagen). Extracted RNA (1.0 μg) was used as a first strand reaction that included random hexamer 
primers and murine leukaemia virus reverse transcriptase (Applied Biosystems). Real-time PCR was 
amplified for glyceraldehydes-3-phosphate dehydrogenase (GAPDH, TaqMan Assay ID: Rn99999916_S1), 
myogenin (myog, TaqMan Assay ID: Rn00567418_m1) [37], MHC class I polypeptide-related sequence B 
(Micb, TaqMan Assay ID: Rn01764378_m1). The reaction was performed with 10 ng of c-DNA, 90 nM PCR 
primers, 25 nM PCR probe and TaqMan universal PCR master mix (Applied Biosystems). The expression 
levels of target genes relative to that of GAPDH were calculated using a comparative Ct method. The 
primers and probes were obtained from Applied Biosystems. 
5.3.7 Statistical analysis 
One-way analysis of variance (ANOVA) was used to evaluate the myogenic gene expression levels of 
cells cultured in different scaffolds. Student-t test was used to compare two groups of data. Statistical 
differences were considered significant if p<0.05. 
5.4 Results and discussion 
5.4.1 Preparation of microgrooved collagen scaffolds 
To control the pore structure of 3D microgrooved scaffolds, parallel lines of frozen ice were prepared by 
dispensing pure water onto a copper plate which was cooled by liquid nitrogen and served as a template to 
prepare the microgrooved scaffolds (Fig. 5.1a,b). A hydrophobic polyfluoroalkoxy film on the copper plate 
was used to deposit frozen lines so that these lines had a nearly semicircular shape in cross-section. Type I 
collagen was chosen to prepare the scaffolds because it can promote the proliferation of skeletal muscle cells 
[38]. By controlling the width of frozen ice lines, scaffolds with different width of microgrooves were 
prepared (120 ± 15, 200 ± 18 and 380 ± 22 μm, named as G120, G200 and G380, respectively) as shown in 
Fig. 1c. The micropatterned scaffolds had aligned concave microgrooves that exhibited a semicircular shape 
in cross-section, which was inherited from the frozen ice line replicates. The depth of the microgrooves of 
scaffolds in Z direction was 65 ± 8 µm for G120, 107 ± 11 µm for G200 and 188 ± 15 µm for G380.  
Scaffolds with a flat surface as a control group (Flat) were prepared without using frozen ice lines. These 
scaffolds had similar porosity (Table 5.1) as determined from the same concentration of collagen used for 
scaffold preparation. 
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Fig. 5.1. Preparation of microgrooved collagen scaffolds. (a) A schematic for the preparation of 
microgrooved collagen scaffolds. (b) Image of frozen ice lines prepared from water dispensing. (c) SEM 
images of different microgrooved collagen scaffolds. Flat: control collagen scaffolds with a flat surface; 
G120, G200, G380: collagen scaffolds with mean microgroove widths of 120, 200, 380 μm, respectively. 
Upper images show the top view and lower images show the vertical cross-sectional view of different 
scaffolds. Scale bar = 100 μm. 
 
Table 5.1. Porosity of different types of scaffolds (mean ± standard deviation, N = 3).  
Scaffold Flat G120 G200 G380 
Porosity (%) 97.2 ± 0.6 97.6 ± 1.1 98.2 ± 0.8 97.3 ± 0.5 
5.4.2 Effects of seeding concentration on formation of cellular bundles 
To study the potential of the microgrooved collagen scaffolds for SMTE, rat L6 skeletal myoblasts were 
firstly seeded at different seeding concentrations onto the G200 scaffolds. After cell seeding at an 
intermediate concentration (2.0×106 cells/ml), L6 myoblasts settled down and adhered in microgrooved 
scaffolds after 24 h, with the majority of myoblasts settled on the lower part of microgrooves (Fig. 5.2a). 
Myoblasts in the microgrooves subsequently contracted into multi-cellular strips after 48 h, and further 
contracted into multi-cellular bundles in microgrooves after 72 h. L6 myoblasts seeded at a low seeding 
concentration (0.4×106 cells/ml) remained homogeneously distributed in microgrooved scaffolds and did not 
form cell bundles or myotubes after culture for 7 d (Fig. 5.2b). L6 myoblasts seeded at an intermediate 
(2.0×106 cells/ml) or high concentration (4.0×106 cells/ml) formed aligned cell bundles in microgrooves and 
fused into some myotubes within cell bundles. The results suggested that the formation of cell bundles was 
dependent on seeding concentration of myoblasts. Myoblasts seeded at a high concentration would enable 
cell-cell interaction that led cells in each microgroove to contract together into cellular bundles and fuse into 
myotubes. However, if the cell seeding concentration was too high (1.2×107/ml), the cells would readily 
overgrow in the microgrooves and on the ridges, forming sheet-like structure that delaminated from the 
microgrooves after 72 hours. 
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Fig. 5.2. Formation of cell bundles in microgrooved scaffolds. (a) SEM images of cell-seeded scaffolds 
(G200, seeding concentration: 2.0×106/ml) after 24 h, 48 h and 72 h culture. Arrows mark cell bundles 
formed in the microgrooves. (b) Cell bundle formation in scaffolds (G200) seeded with different 
concentrations of myoblasts (0.4, 2.0, 4.0×106/ml) after 7 d culture. Myoblasts were visualized using F-actin 
staining; myotube formation was shown using MHC staining. Dashed squares mark cell bundle in the 
microgrooves and arrows mark myotubes in microgrooves. Scale bar = 200 μm.  
5.4.3 Effects of microgroove widths on formation of cellular bundles 
L6 skeletal myoblasts were seeded onto the microgrooved scaffolds with different width of 
microgrooves (G120, G200, G380 and Flat control) at the intermediate concentration (2.0×106 cells/ml). 
F-actin staining of myoblasts cultured in the microgrooved scaffolds for 7 d showed that the scaffolds could 
guide formation of cell bundles in microgrooves (Fig. 5.3a). Scaffolds with wide microgrooves (G200 and 
G380) enabled formation of discrete, parallel cell bundles during 14 d culture. Scaffolds with narrow 
microgrooves (G120) resulted in formation of some cell bundles in microgrooves and mostly cellular flakes 
covering most of the area of scaffolds.  Myoblasts cultured on flat scaffolds showed some aggregation into 
clusters and no cell bundle formation. Staining of myosin heavy chain (MHC) showed that well-aligned 
myotubes formed within cell bundles in G200 and G380, while in G120 some myotubes were aligned in 
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microgrooves and other myotubes possibly in cellular flakes had random orientation (Fig. 5.3b). On flat 
scaffolds most of myotubes formed in cell aggregates and had random orientation. These results indicated 
that the formation and alignment of cell bundles in microgrooved scaffolds were dependent on the size of 
microgrooves.  
 
Fig. 5.3. Myotube formation in different microgrooved scaffolds after culture for 7 (a) and 14 d (b) (seeding 
concentration: 2.0×106 cells/ml). Myoblasts were visualized using F-actin staining; myotube formation was 
shown using MHC staining. Scale bar = 200 μm. 
5.4.4 Multi-layered skeletal muscle bundles 
The confocal laser scanning microscopy (CLSM) images of cross-sections of cell bundles (XZ plane) 
showed that the cell bundles changed from flat bundles at day 7 to circular bundles at day 14 (Fig. 5.4a), 
indicating cellular contraction in cell bundles from day 7 to day 14. CLSM images of cell bundles (G200 and 
G380, day 14) at different depths in z direction showed that cell bundles had a thickness of 116 ± 14 μm 
(G200) or 120 ± 40 μm (G380) (Fig. 5.4b). Multi-cellular bundle could be engineered using microgrooved 
scaffolds.  
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Fig. 5.4. Multi-layered skeletal muscle bundles (seeding concentration: 2.0×106 cells/ml). (a) z-stack CLSM 
images (XZ, XY and YZ planes) of cell bundle that formed in G200 and G380 scaffolds after 7 d and 14 d 
culture. Samples were stained for F-actin and nuclei. (b) Optical sections of stained cell bundle in different z 
depths as shown in the images (10-120 µm). Samples were stained for F-actin, MHC and nuclei. 
5.4.5 Cell alignment in engineered muscle bundles 
To check the cell alignment within each cell bundles, cell nuclei and F-actin were stained and visualized 
using CLSM. Analysis of cell nucleus alignment angle (Fig. 5.5a,b) and F-actin alignment (Fig. 5.5c) of 
myoblasts showed that the long axis of cell nuclei and F-actin were well aligned in the direction of 
microgrooves in G200 and G380. G120 scaffolds also guided the alignment of cell nuclei and F-actin but 
showed less satisfactory results compared with G200 or G380.  
Many studies used groove/ridge micro- and nanopatterns with small periodic features (<100 µm) to 
guide the alignment of cells in monolayer [17, 18, 39-41]. It has been difficult to guide the formation of 
well-aligned cell bundles for SMTE in a 3D environment. Our results suggested that concave microgrooves 
with large sizes (200-380 µm) could guide the contraction of cell populations of multilayers to form cell 
bundles with well-aligned cells. For these scaffolds (G200 and G380), each microgroove had enough space 
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to hold seeded cells and facilitated subsequent contraction of cells in each microgroove leading to formation 
of well-aligned cell bundles. For scaffolds with small width microgrooves (G120), however, the seeded cells 
overfilled the limited space of each microgroove and overgrew on the scaffold which led to formation of 
cellular flakes and less organized cell bundles.   
The 3D microgrooved scaffolds had some advantages over 2D patterned surfaces or cell-sheet 
technology. 2D patterned surfaces or cell-sheet technology can enable formation of a thin layer of aligned 
muscle tissue, but harvest of the tissue usually leads to formation of unorganized tissue due to cellular 
contraction and loss of anisotropic morphology [42]. In addition, thin layers of aligned muscle tissue need to 
be stacked layer by layer to form thick, anisotropic muscle tissues, which is tedious and difficult [42, 43]. In 
contrast, our microgrooved scaffolds can enable thick, well aligned muscle tissue with simple manipulation. 
Microgrooved hydrogels have been used to enable the formation of aligned myotubes. Cells cultured in 
the microgrooved hydrogels show high alignment during a short culture period while cells become less 
aligned after 8 days culture [36]. However, the concave microgrooves (semicircular shape in cross-section) 
in this study enabled myoblasts to settle down, proliferate and differentiate along the central axis of each 
microgrooves, leading to the formation of well-aligned muscle bundle even after 14 days culture. The high 
cellular alignment in our microgrooved scaffolds might attribute to the concave microgroove together 
with the porous structures of the scaffolds. 
5.4.6 Myogenic gene expressions of cells in muscle bundles 
The expression levels of two myogenesis-related genes, myogenin and myosin heavy chain (MHC), 
were quantified by using real-time PCR (Fig. 5.5d). For all scaffold samples, the expression levels of both 
genes decreased a little from day 7 to day 14, although not statistically significant. While microgrooved 
scaffolds guided the alignment of myoblasts, there was no significant difference of myogenic gene 
expression levels among different microgrooved scaffolds. Similar gene expression levels of the cells 
cultured in the scaffolds should be due to the same fusion medium used in the cell culture, which was 
considered as the primary factor that determined cell differentiation. When being cultured in the 
micropatterned scaffolds, cells formed bundle structures with good cell-cell interaction. After cell-cell 
interaction reached a base level, the differentiation of myoblasts should be determined by culture medium, 
other than the micropattern structures. These results were in agreement of previous studies which showed 
that different macro-channels or micro-scale topography did not affect the differentiation of either primary or 
C2C12 myoblasts [17, 39, 44]. 
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Fig. 5.5. Cell alignment within cell bundles in different microgrooved scaffolds (G120, G200 and G380) and 
expression of myogenic genes. (a) CLSM images of cell nuclei. (b) distribution of nuclei alignment angle. (c) 
F-actin staining of myoblasts with counterstained nuclei. a-c, samples were cultured for 14 d. (d) Expression 
of genes encoding myogenin and MHC class I polypeptide-related sequence B (MHC). No significant 
difference (p > 0.05) in expression levels of either gene among different scaffolds after 7 or 14 d of cell 
culture. Seeding concentration: 2.0×106 cells/ml. 
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5.4.7 Formation of organized multi-layered muscle tissue 
Culture of myoblasts in G200 (seeding concentration: 4.0×106 cells/ml) for 2 weeks resulted in 
formation of organized multi-layered muscle tissue. HE staining and F-actin staining of engineered muscle 
tissue showed that the tissue filled the microgrooved scaffolds and cells within the tissue were highly aligned 
along the longitudinal direction (Fig. 6a-c). Immunostaining of MHC and laminin showed that cells had high 
expression of MHC and synthesis of muscle ECM in the microgrooved collagen scaffolds (Fig. 5.6d-f).  
Cell culture systems using hydrogels without micropattern structures have also reported to generate 
multi-layered muscle bundle tissues [45-47]. However, the systems usually lead to outer region with densely 
packed cells and an acellular core [47, 48]. Engineering muscle tissue by 3D microgrooved porous scaffolds 
provided an alternative for muscle tissue engineering. The live/dead staining of the engineered tissues in our 
porous scaffolds showed that the cells within the tissues had a high viability and no necrosis of central core 
(Fig. 5.7), possibly due to the ease of oxygen diffusion and nutrient transfer in the porous structures. 
Myoblasts after 2-week culture aligned and had high expression of myosin heavy chain, which is closely 
related to the contractile function of myotube bundles [49]. Myoblasts after 4-week culture had even higher 
expression of myosin heavy chain (Fig. 5.8). The micropatterned porous scaffolds could regenerate 
well-aligned, highly differentiated and viable muscle bundles. Therefore, the 3D microgrooved collagen 
scaffolds may be used to engineer well-organized multi-layered muscle tissue that can be directly implanted 
for repairing diseased skeletal muscle or cardiac tissue. 
 
Fig. 5.6. Formation of organized multi-layered muscle tissue. Myoblasts were seeded at the concentration of 
4.0×106 cells/ml into G200 scaffolds and cultured for 2 weeks. HE staining of (a) transversal cross-sections 
and (b) longitudinal cross-sections of engineered muscle tissue. (c) F-actin staining of the tissue. (d-f) MHC, 
laminin immunostaining and merged images of engineered muscle tissue. Cell nuclei were stained with 
DAPI. Scale bar = 200 μm. 
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Fig. 5.7.  Live/dead staining of cells in muscle bundle tissue after 2-week culture. Confocal images were 
scanned at different depths (30, 60, 90 um from the top) of engineered tissue. Green: live cells; red: dead 
cells. Myoblasts were seeded at the concentration of 4.0×106 cells/ml into G200 scaffolds and cultured for 2 
weeks. Scale bar = 200 μm. 
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Fig. 5.8. Maintenance of highly organized and differentiated muscle bundle tissue after long-term culture. 
Myoblasts were seeded at the concentration of 4.0×106 cells/ml into G200 scaffolds and cultured for 4 weeks. 
(a-b) F-actin/DAPI staining of the tissue. (c) DAPI staining of nuclei , MHC immunostaining and merged 
images of engineered muscle tissue. Scale bar = 200 μm. 
5.5 Conclusions 
In summary, 3D collagen scaffolds with concave microgrooves that mimic muscle basement membrane 
were prepared using liquid dispensing and freeze-drying. By culturing L6 myoblasts in the microgrooved 
scaffolds, highly aligned and multi-layered muscle bundle tissues were engineered by controlling the size of 
microgrooves and cell seeding concentration. Myoblasts in the engineered muscle tissue were well-aligned 
and had high expression of myosin heavy chain and synthesis of muscle extracellular matrix. The 
microgrooved scaffolds of different groove sizes did not affect the expression levels of myogenic genes. The 
organized multi-layered muscle tissue engineered from microgrooved collagen scaffolds may be used for 
implantation to repair or restore the function of diseased muscles.   
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Biomimetic assembly of HUVECs and muscle cells in the 
microgrooved collagen scaffolds 
 
 
6.1 Summary  
Porous polymer scaffolds can be used to engineer 3D tissues for tissue repair. However, conventional 
scaffolds are not compatible for regeneration of anisotropic tissues such as muscle and nerve which have 
well aligned cells, blood vessels and extracellular matrix of ordered structure. Micropatterned porous 
scaffolds with anisotropic microstructure are desirable for recapitulation of tissue anisotropy. We developed 
microgrooved collagen porous scaffolds with parallel and concave microgrooves by using ice template and 
freeze-drying to coculture skeletal muscle myoblasts and vascular endothelial cells. When the cells are 
seeded at a proper ratio and concentration, the unique microstructure of the scaffolds triggers spontaneous 
assembly of the cells into vascularized and well ordered muscle tissue which mimic normal muscle tissue 
organization. 
6.2 Introduction  
Living tissues can be engineered by culturing cells in polymer scaffolds to repair or restore the function of 
diseased tissues. Engineering three-dimensional (3D) thick tissues and maintaining their viability in vivo 
necessitates the vascularization of engineered tissues.[1-3] Vascularization of engineered tissue can enable the 
delivery of nutrients and oxygen and removal of waste matter from living tissues. On the other hand, many types 
of tissues such as skeletal muscle and limb bones have well ordered tissue structure and vasculature to maintain 
the viability of these tissues.[4, 5] Engineering vascularized 3D tissues with well ordered structure remains a 
challenge in tissue engineering. In this study, microgrooved collagen scaffolds with parallel, concave 
microgrooves are fabricated to coculture skeletal muscle myoblasts and vascular endothelial cells. When the cells 
are seeded at a proper ratio and concentration, the unique microstructure of microgrooved scaffolds trigger 
spontaneous assembly of the cells into vascularized, well ordered muscle tissue which mimic the normal muscle 
tissue organization. 
Many approaches have been used to engineer vascularized tissues, such as the use of 2D micropatterned 
surfaces, microfabricated conduits in hydrogel and 3D porous scaffolds.[3, 6] Although 2D micropaterned 
surfaces could guide the assembly of vascular endothelial cells and muscle cells into ordered cell sheets, they are 
not suitable to engineer thick tissues.[7, 8] Microfabricated conduits in hydrogel could be used to obtain 
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endothelialized network but complicated perfusion bioreactors are required for the cell culture.[9, 10] 3D porous 
scaffolds with incorporation of vascularization-promoting growth factors or coculture of endothelial cells and 
cells of target tissue can be used to engineer vascularized 3D tissue, but these scaffolds cannot guide the formation 
of highly ordered tissues such as muscle.[11, 12] 
In this study, we used 3D microgrooved collagen scaffolds to engineer vascularized muscle tissue with 
highly ordered tissue organization. The 3D microgrooved structure of porous scaffolds can provide physical cues 
to guide the controlled assembly of human umbilical vascular endothelial cells (HUVECs) and L6 rat skeletal 
myoblasts into ordered tissue. Collagen as the major component of extracellular matrix can provide biological 
cues to regulate the cell migration, proliferation and vessel morphogenesis of vascular endothelial cells.[13, 14] 
Microgrooved collagen scaffold, flat collagen membrane and open porous collagen scaffold were used to study 
the effects of scaffold architecture on the cell assembly. The ratio of endothelial cells in cocultures and the 
concentration of seeded cells in microgrooved scaffolds were varied to study their effects on vascularization of 
engineered muscle tissue. 
6.3 Experiments  
6.3.1 Preparation of microgrooved collagen scaffolds 
Microgrooved collagen scaffolds were prepared from ice line template and 1 wt.% collagen solution 
(solvent: 10% ethanol). Ice line template was prepared by dispensing pure water onto a hydrophobic PFA 
film-wrapped copper plate that was cooled by liquid nitrogen. Water droplets were dispensed from a moving 
nozzle of a liquid dispenser (MJET-3-CTR, Musashi Engineering Inc.), forming frozen ice lines on the 
copper plate. The size of the droplets and hence the width of ice lines were controlled by the pumping 
pressure (0.001 MPa) and type of nozzle (34G). The movement of nozzle was controlled by CAD programs. 
Ice line template was balanced at -5 ºC for 20 min and covered with cooled collagen solution in a silicon 
mold (thickness: 500 µm). The construct were cooled in liquid nitrogen for 10 min and freeze-dried for 24 h.  
6.3.2 Preparation of flat collagen membrane and open-pore collagen scaffolds 
Flat collagen membrane were prepared by freezing the collagen solution in a silicon frame mold 
(thickness: 500 µm) in the liquid nitrogen for 10 min and freeze-drying. Open-pore collagen scaffolds were 
prepared by freezing the collagen solution in the silicon mold (thickness: 3 mm) at -80 ºC and freeze-drying. 
All of the scaffolds were crosslinked (8h, RT) by using 50 mM 1-ethyl-(dimethylaminopropyl) carbodiimide 
dissolved in 80:20 ethanol/water solvent and freeze-dried before cell culture. The skin layer of open-pore 
collagen scaffolds was cut away before cell culture. 
6.3.3 Scanning electron microscopy 
The collagen scaffolds were cut with a sharp blade and fixed with carbon tape and coated with platinum. 
Coated samples were observed at an acceleration voltage of 10 kV by using a scanning electron microscope 
(JSM-5610, JEOL).  
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6.3.4 Culture of myoblasts and HUVECs in scaffolds 
L6 skeletal myoblasts (ATCC® CRL-1458™) were subcultured in growth medium (Dulbecco's 
Modified Eagle Medium (D8437) supplemented with 10% fetal bovine serum and 10% horse serum). 
HUVECs (C2519A, Lonza) were subcultured in EGM2 medium. The two types of cells were harvested and 
mixed to prepare cell suspensions for cell seeding. The ratio of myoblasts to HUVECs varied from 1:0, 3:1 
to 1:1 and the total seeding concentration varied from 1 × 106, 4 × 106 to 6 × 106 cells/ml. All scaffolds were 
punched and cut into circular shape (diameter = 10 mm; thickness = 500 µm) and sterilized before cell 
seeding. Each scaffold was put in one well of 12-well plate and confined in a glass ring (inner diameter=10 
mm). 2 ml of culture medium (1:1 growth medium/EGM2) was added in each well and 200 µl of cell 
suspension was dropped into the scaffolds. Seeded scaffolds were cultured in 1:1 growth medium/EGM2 for 
48 hours and 1:1 differentiation medium/EGM2 for 2 weeks. The differentiation medium were D8437 
supplemented with 2% horse serum. 
6.3.5 Immunostaining of cocultured cells 
Seeded scaffolds were harvested at different incubation time and fixated by using 4% paraformaldehyde 
(20 min, room temperature (RT)). Samples were rinsed in phosphate buffered saline (PBS), permeabilized in 
0.2 % Triton X-100 (1 h, RT) and blocked in 1% bovine serum albumin (BSA) (30 min, RT) on a rocker.[15] 
Primary antibody were diluted in 1% BSA and incubated with the samples overnight at 4 ºC. The samples 
were rinsed in PBS and incubated with secondary antibody (1 h, RT). F-actin were stained by using Alexa 
Fluor 488 Phalloidin or Alexa Fluor 594 Phalloidin (Thermo Fisher Scientific). Cell nuclei were stained with 
Cellstain-DAPI Solution (Dojindo) (10 min, RT). Samples were incubated in antibody and dye solutions on a 
rocker. The primary antibodies were Monoclonal Mouse Anti-Human CD31 antibody (Clone JC70A, Dako) 
(1:40 dilution) and MF20 (Developmental Studies Hybridoma Bank) (1:300 dilution). The secondary 
antibody was Goat anti-Mouse IgG Secondary Antibody (Life Technologies) (1:500 dilution). 
6.4 Results and discussion 
6.4.1 Microstructure of collagen scaffolds 
3D microgrooved collagen scaffolds were prepared by using liquid dispensing and freeze-drying 
method. A moving nozzle of a dispenser ejected water droplets onto a polyfluoroalkoxy (PFA) film-wrapped 
copper plate cooled by liquid nitrogen. The rapid freezing of the ejected droplets on the plate resulted in 
formation of ice lines. The hydrophobic PFA film resulted in the semicylindrical shape of ice lines. The size 
of water droplets and hence the width of ice lines on the copper plate were controlled by the air pressure that 
pumped water out of the nozzle (0.001 MPa) and the size of nozzle (34G). Parallel ice lines were prepared by 
controlling the movement of the dispensing nozzle with CAD programs. These parallel ice lines were 
covered with cooled collagen solution in silicon mold and freeze-dried to get microgrooved scaffolds. Flat 
collagen membranes (Flat) and open porous collagen scaffolds were also prepared for cell culture.  
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Fig. 6.1. The microstructure of (a-c) microgrooved scaffolds (G200), (d) flat collagen membrane (Flat) and 
(e) open-porous collagen scaffolds (Open-pore). a, b, d, e: surface view; c: vertical cross sectional view. 
 
Collagen scaffolds with different structures were used for coculture of myoblasts and HUVECs to study 
the effects of scaffold structure on cell assembly. Microgrooved collagen scaffolds with the average 
microgroove width of 200 µm (G200) were used for the coculture because previous work showed G200 
enabled more ordered muscle tissue formation than narrower (120 µm) or wider microgrooves (380 µm).[16] 
G200 microgrooved scaffolds had parallel microgrooves (width: 205 ± 12 µm; height: 103 ± 8 µm) with 
concave structure in vertical cross section which mirrored the ice line template used to prepare the scaffolds 
(Fig. 6.1a-c ). Flat collagen membranes had a flat and dense surface, which was resulted from the rapid 
freezing of collagen solution (Fig. 6.1d). Open-pore collagen scaffolds had a porous morphology with 
uncontrolled structure (Fig. 6.1e).  
6.4.2 The effect of scaffold structure on cell assembly 
The cell assembly of myoblasts and HUVECs were studied after culturing the two types of cells in these 
3 types of scaffolds for 12 h, 24 h or 48 h (Fig. 6.2). After 12 h incubation, myoblasts and HUVECs 
homogenously adhered on the 3 types of collagen scaffolds. After 24 h incubation, HUVECs aggregated into 
individual cellular islands surrounded by myoblasts. After 48 h incubation, the HUVEC islands remained in 
Flat and Open-pore scaffolds. However, myoblasts contracted in the microgrooves and formed cell bundle 
tissue in which the HUVEC islands fused into tubule-like structure along the microgrooves. 
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Fig. 6.2. The assembly of myoblasts and HUVECs in flat collagen membrane (Flat), open porous collagen 
scaffolds (Open-pore) and microgrooved collagen scaffolds (G200). Myoblasts and HUVECs at the ratio of 
3:1 (a-c) or 1:1 (d) were seeded in 3 types of scaffolds, with a fixed total seeding concentration (4×106 
myoblasts and HUVECs). Confocal microscopic images of XY, YZ and XZ planes of seeded constructs were 
obtained after the constructs were cultured for 12 h, 24 h or 48 h. Cells were stained with F-actin (green) and 
nuclei (blue); HUVECs were stained using anti-hCD31 antibody (red).   
6.4.3 The effect of HUVEC ratio and seeding concentration on cell assembly 
The effect of seeding ratios and total seeding concentrations of myoblasts and HUVECs on cell 
assembly in microgrooved scaffolds were shown in Fig. 6.3. With a proper seeding concentration (4 × 106 
cells/ml), monoculture (1:0) and cocultures (3:1 and 1:1) in microgrooved collagen scaffolds all formed 
well-aligned muscle bundle tissue. However, the ratios of myoblasts and HUVECs affected the formation of 
tubule-like structure (Fig. 6.3a and Fig. S6.1). A low ratio of HUVECs in the coculture (3:1) resulted in 
formation of  intermittent tubule-like structure from HUVECs and some small HUVEC aggregates that 
were not fused to the tubule-like structure. A high ratio of HUVECs in the coculture (1:1) resulted in 
formation of continuous tubule-like structure from HUVECs and the majority of HUVECs were fused to the 
tubule-like structure. The assembly of myoblasts and HUVECs were also affected by the total cell seeding 
concentrations. With a fixed ratio of myoblasts and HUVECs (1:1), the cocultures from an intermediate 
seeding concentration (4 × 106 cells/ml) formed muscle bundle tissue with aligned HUVEC tubules. A low 
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seeding concentration (1 × 106 cells/ml) resulted in formation of cellular spheroids in the microgrooved 
scaffolds, while a high seeding concentration (6 × 106 cells/ml) resulted in formation of HUVEC sheet 
covering the underlying muscle bundle tissue.   
 
Fig. 6.3. The assembly of myoblasts and HUVECs seeded at (a) different ratios (1:0, 3:1 or 1:1, total seeding 
concentration=4 × 106 cells/ml) or (b) different total seeding concentrations (1 × 106, 4 × 106, or 6 × 106 
cells/ml; ratio=1:1) in microgrooved scaffolds after 1-week culture. Cells were stained with F-actin (green) 
and nuclei (blue); HUVECs were stained using anti-hCD31 antibody (red). Scale bar = 200 µm.   
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Fig. S6.1. The assembly of myoblasts and HUVECs seeded at (a) different ratio (1:0, 3:1 or 1:1, total cell 
seeding concentration=4×106 cells/ml) in the microgrooved scaffolds after 1 week culture. Cells were stained 
with F-actin (green) and nuclei (blue); HUVECs were stained using anti-hCD31 antibody (red). Scale bar = 
50 µm.   
6.4.4 Formation of vascularized and well-ordered muscle 
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Vascularized and well-ordered muscle tissue could be engineered by coculturing myoblasts and 
HUVECs in the microgrooved scaffolds (Fig. 6.4). Confocal microscopic images of cocultures in the 
microgrooved scaffolds showed that HUVECs assembled into tubule-like structure that was incorporated 
within the aligned muscle bundle tissue from myoblasts (Fig. S6.2). While seeding a low ratio of HUVECs 
(3:1) resulted in intermittent tubules, seeding a high ratio of HUVECs (1:1) resulted in continuous tubules 
from HUVECs. By coculturing the cells in a medium of low serum level (2% serum; differentiation 
medium:EGM2=1:1) for 2 weeks, myoblasts fused into muscle bundle tissue that showed a high expression 
of myosin heavy chain (MHC) proteins (Figure 6.4b), which indicated the maturation of myotubes within the 
tissue. In addition, the muscle cells within the  tissue were highly aligned as shown by the immunostaining 
of the MHC and F-actin.   
 
 
Fig. 6.4. The formation of vascularized, well-ordered muscle bundle tissue within microgrooved scaffolds 
after 2-week culture. (a) Confocal microscopic images of XY, YZ and XZ planes of seeded constructs 
showing the cell assembly in scaffolds (seeding ratio=3:1 or 1:1). Cells were stained with F-actin (green) and 
nuclei (blue); HUVECs were stained using anti-hCD31 antibody (red).  (b) The maturation of myotubes in 
the well ordered muscle bundle tissue. Myosin heavy chain protein (MHC) was stained in green and F-actin 
were stained in red. Cell nuclei were stained in blue. 
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Figure S6.2. HE staining of tubule-like structure assembled from coculture of HUVECs and myoblasts in the 
microgrooved scaffolds after 2-week culture. Seeding ratio=1:1, total cell seeding concentration = 4×106 
cells/ml. 
 
Based on the results we proposed a mechanism for the assembly of myoblasts and HUVECs in the 
microgrooved scaffolds (Fig. 6.5). A homogenous mixture of myoblasts and HUVECs were seeded and 
adhered the scaffolds. Subsequently the cells proliferated and migrated and HUVECs formed cellular islands 
surrounded by myoblasts. With the contraction of myoblasts within the microgrooves, myoblasts formed cell 
bundle tissue in which the HUVEC islands fused into tubular-like structure. Further culturing the assembled 
cells in the microgrooved scaffolds led to formation of vascularized muscle tissue with ordered structure. 
Vascular endothelial cells are polar cells that have the apical surface that exclude adhesion to extracellular 
matrix (ECM) proteins and the basal surface that adhered on the underlying basement membrane 
proteins.[17] The polar vascular endothelial cells can assemble into capillary-like networks within ECM 
matrix such as collagen gels.[18] Endothelial cells were also found to form individual cell aggregates when 
cultured with cells of another type.[5] In this study, the aggregation of HUVEC into islands might be that 
HUVECs migrated together to exclude the surrounding myoblasts or the ECM synthesized by myoblasts. 
Scaffold architecture affected the subsequent assembly of the cells. Unlike the Flat collagen membranes or 
the Open-pore collagen scaffolds which retained the HUVEC islands during the coculture (Fig. 6.2a,b; 
24h-48h), microgrooved collagen scaffolds triggered the contraction of myoblasts to the central axis of 
concave microgrooves, causing fusion of HUVEC islands into tubule-like structure and formation of 
vascularized muscle bundle tissue. 
 
 
Fig. 6.5. The proposed mechanism for the assembly of myoblasts and HUVECs within the microgrooved 
scaffolds. (a) A homogenous mixture of myoblasts and HUVECs were seeded in microgrooved scaffolds. (b) 
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Cells proliferated and HUVECs assembled into cellular islands surrounded by myoblasts. (c) The contraction 
of myoblasts within the microgrooves led to the formation of cell bundle with tubule-like structure. 
 
Apart from the scaffold architecture, the seeding ratio of HUVECs and the total seeding concentration 
also affected the assembly of the two types of cells. Seeding myoblasts and HUVECs at the ratio of 3:1 or 
1:1 did not affect the formation of muscle bundle tissue when compared with the monoculture (1:0). A low 
ratio of HUVECs in the coculture (3:1) resulted in intermittent tubule-like structure from HUVECs and some 
small HUVEC aggregates not incorporated into the tubules. The reason might be that less HUVECs in the 
coculture had smaller frequency of encountering each other and fusing together.[19]  A high ratio of 
HUVECs in the coculture, however, resulted in formation of continuous tubule-like structure and the 
majority of HUVECs were incorporated within the tubules. A proper seeding concentration was required to 
form muscle bundle tissue with HUVEC tubules. The two types of cells seeded at a low concentration (1 × 
106 cells/ml) formed cellular spheroids rather than cell bundles in the scaffolds, which is in agreement of our 
previous study and other studies.[16, 20] Cells seeded at a high concentration (6 × 106 cells/ml) would form a 
layer of HUVEC covering the muscle bundle tissue, which could be resulted from the encountering of 
HUVECs in neighboring microgrooves and adhesion of these cells into a layer above the muscle cells to 
reestablish the polar HUVEC environment.[19, 21]  
Coculturing vascular endothelial cells and target tissue cells has been used to engineer vascularized 
tissues.  Endothelial cells have been cocultured with other types of cells such as muscle cells or fibroblasts 
in 2D polymer substrates, hydrogel or porous scaffolds to engineer vascularized tissue, but these materials 
lack the topography that guide the formation of well-organized tissues such as muscle.[22-25] The assembly 
of HUVECs within myoblast sheets into capillary networks also lack the organization of skeletal muscle.[26] 
Recently, thermo-responsive micropatterns were used to generate anisotropic myoblast sheets to guide the 
assembly of endothelial cells, but the multiple steps of harvesting and stacking the cell sheets was tedious.[5] 
With proper seeding ratio and seeding concentration in microgrooved collagen scaffolds, vascular 
endothelial cells and muscle cells could spontaneously assemble into well-aligned vascularized muscle 
bundle tissue. To the best of our knowledge, this is the first work reporting the spontaneous assembly of 
cocultured cells into well-ordered vascularized tissue by using micropatterned scaffolds.      
6.5 Conclusion 
In summary, microgrooved collagen scaffolds with parallel, concave microgroove patterns have been 
fabricated to coculture muscle cells and vascular endothelial cells. Myoblasts and HUVECs in the 
microgrooved scaffolds spontaneously assembled into well-ordered vascularized muscle bundle tissue. The 
seeding ratio of HUVECs and the total seeding concentration of HUVECs and myoblasts affected the cell 
assembly in the microgrooved scaffolds. Culturing different types of cells in the microgrooved collagen 
scaffolds could be a useful tool to engineer vascularized tissue of highly ordered structure, or to study the 
cell-cell interaction or cell-material interaction within a 3D micropatterned material or to obtain an in vitro 
angiogenesis model. 
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Concluding remarks and future prospects 
 
 
 
 
 
7.1 Concluding remarks  
 
This thesis summarizes the development of natural polymer scaffolds with controlled microstructure to 
engineer cartilage and skeletal muscle, and study the effect of scaffold properties (composition, biophysical 
cues) that affect cell-cell and cell-material interactions in 3D culture. 
Low molecular weight salts were used to suppress polyion complex(PIC) formation in 
collagen/hyaluronic acid(HA) suspensions during scaffold preparation. PIC formation was found to be 
dependent on the ionic strength of the suspension. The suppression of PIC formation resulted in collagen/HA 
scaffolds with homogeneous pore structure and remarkably enhanced mechanical property. Collagen/HA 
scaffolds prepared under suppression of PIC formation promoted proliferation of dermal fibroblasts and 
upregulated the expression of genes encoding EGF, VEGF and IGF-1.   
Homogeneous collagen/HA scaffolds with well-controlled and interconnected pore structure were 
prepared to study the effect of high molecular HA on chondrocyte behavior. Collagen/HA scaffolds were 
prepared by suppression of PIC formation between collagen and HA and using ice particulates as porogen. 
The pore structure and mechanical property of collagen/HA scaffolds and collagen scaffolds could be well 
controlled. High molecular weight HA in collagen/HA scaffolds inhibited the cellular proliferation, synthesis 
of sulfated glycosaminoglycan (sGAG) and cartilage ECM, compared with the results of collagen scaffolds. 
The results should provide additional information on the effects of HA in porous scaffolds on the 
chondrocyte behavior in 3D culture. 
Gelatin porous scaffolds with homogeneous and open pores were developed to engineer cartilage tissue 
in vitro. Gelatin scaffolds were prepared by using ice particulates and freeze-drying. The pore structure and 
mechanical property of gelatin scaffolds could be well controlled by using different ratios of ice particulates 
to gelatin solution and different concentrations of gelatin. Gelatin scaffolds prepared from ≥ 70% ice 
particulates enabled homogeneous seeding of bovine articular chondrocytes throughout the scaffolds and 
formation of homogeneous cartilage ECM. While soft scaffolds underwent cellular contraction, stiff 
scaffolds resisted cellular contraction and had significantly higher cell proliferation and synthesis of sulfated 
glycosaminoglycan. Compared with the gelatin scaffolds prepared without ice particulates, the gelatin 
Concluding remarks and future prospects 
105 
 
scaffolds prepared with ice particulates facilitated formation of homogeneous cartilage tissue with 
significantly higher compressive modulus. The gelatin scaffolds with highly open-pore structure and good 
mechanical property can be used to promote chondrocyte functions for in vitro tissue-engineered cartilage.   
3D porous collagen scaffolds with anisotropic and concave microgrooves were developed to engineer 
skeletal muscle tissue. Highly aligned and multi-layered muscle bundle tissues were engineered by 
controlling the size of microgrooves and cell seeding concentration. Myoblasts in the engineered muscle 
tissue were well-aligned and had high expression of myosin heavy chain and synthesis of muscle 
extracellular matrix. The microgrooved collagen scaffolds could be used to engineer organized multi-layered 
muscle tissue for implantation to repair/restore the function of diseased tissues. 
Microgrooved collagen scaffolds with anisotropic microgrooves, non-patterned collagen scaffolds and 
flat collagen scaffolds were prepared to coculture of skeletal muscle myoblasts and vascular endothelial cells. 
When the two types of cells were seeded at a proper ratio and concentration, the unique microstructure of 
microgrooved scaffolds triggered the spontaneous assembly of cells into vascularized anisotropic muscle 
tissue that mimicked the normal muscle tissue organization.  
In conclusion, natural polymer scaffolds with homogeneous, open-pore structure can be used to 
engineer homogeneous tissues. Natural polymer scaffolds with anisotropic micropatterned structure can 
guide cell alignment to engineer anisotropic tissues. Natural polymer scaffolds with controlled 
microstructures can be used to study the effects of composition and biophysical cues (stiffness, topography) 
on cell-cell and cell-material interactions in 3D material environment. 
 
7.2 Future prospects 
 
The study described in this thesis was focused on the design of scaffold microstructures for tissue 
engineering and investigation of cell behaviors in the 3D material environment. The cell types used to study 
the potential of the scaffolds for tissue engineering were limited to differentiated cells such as articular 
chondrocytes and progenitor cells such as skeletal myoblasts. However, some cell types such as 
chondrocytes have limited cell number and harvesting a great number of these cells for tissue engineering is 
difficult. In the future work, stem cells can be subcultured and differentiated to get a specific type of cells, 
which can be combined with the natural polymer porous scaffolds to engineer a specific type of tissue. For 
example, mesenchymal stem cells can be cultured in the gelatin scaffolds with homogeneous and open-pore 
structure and differentiated into chondrocytes for cartilage tissue engineering. Skeletal muscle stem cells 
(satellite cells) can be subcultured and differentiated in microgrooved collagen scaffolds to engineer skeletal 
muscle tissue. 
The natural polymer porous scaffolds were used to culture cells in vitro to engineer cartilage tissue and 
skeletal muscle. However, the in vitro cell culture conditions are different from the in vivo environment. To 
further validate the feasibility of these scaffolds for tissue engineering applications, the engineered tissues 
such as cartilage and skeletal muscle need to be implanted into large-animal models to check the maturation 
and function of engineered tissues and the integration of the engineered tissues with native tissues. 
The scaffold fabrication methods of this study (the use of homogeneous polymer solution by 
suppression of polyion complex and the use of sacrificial templates such as ice particulates and 
micropatterned ice lines) can be used to prepare polymer scaffolds to engineer other types of tissues with 
homogeneous structure (such as liver) or with anisotropic structure (such as cardiac muscle and nerve). 
Co-culture of vascular endothelial cells and the cells of target tissue in the polymer scaffolds with controlled 
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microstructures can enable vascularization of engineered tissues, which is vital for engineering of large and 
thick living tissues and maintaining their viability in vivo.  
The fabrication techniques can also be used to prepare polymer scaffolds for implantation in animal 
models to study material-tissue interactions such as foreign body response. Many studies reported that the 
pore structure of synthetic polymer based scaffolds affect the foreign body response to the implanted 
scaffolds. Natural polymer scaffolds with controlled and open-pore microstructure can be used to study 
tissue response, which can guide the design of biomaterial for long-term tissue regeneration or the surface 
microstructure of medical implants. 
The polymer scaffolds with controlled microstructure can also be combined with drug carriers and 
implanted to achieve controlled release of drug for tissue regeneration or other therapeutic applications. Drug 
carriers such as polymer micro- or nano-particles can encapsulate drug and be incorporated into the scaffolds. 
The controlled microstructure of polymer scaffolds may enable the reproducible, controlled and sustainable 
drug delivery. 
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